US11931966B2 - Systems and methods for optical assessments of bioink printability - Google Patents

Systems and methods for optical assessments of bioink printability Download PDF

Info

Publication number
US11931966B2
US11931966B2 US16/964,899 US201916964899A US11931966B2 US 11931966 B2 US11931966 B2 US 11931966B2 US 201916964899 A US201916964899 A US 201916964899A US 11931966 B2 US11931966 B2 US 11931966B2
Authority
US
United States
Prior art keywords
bioprinter
bioink
printing
imaging apparatus
optical imaging
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US16/964,899
Other versions
US20210031456A1 (en
Inventor
Patrick Thayer
Hany Abushall
Hector Martinez
Erik Gatenholm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cellink Bioprinting AB
Original Assignee
Cellink Bioprinting AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellink Bioprinting AB filed Critical Cellink Bioprinting AB
Priority to US16/964,899 priority Critical patent/US11931966B2/en
Assigned to CELLINK AB reassignment CELLINK AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GATENHOLM, ERIK, MARTINEZ, HECTOR, THAYER, Patrick, ABUSHALL, Hany
Publication of US20210031456A1 publication Critical patent/US20210031456A1/en
Assigned to BICO GROUP AB reassignment BICO GROUP AB CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: CELLINK AB
Assigned to BICO GROUP AB reassignment BICO GROUP AB CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: CELLINK AB
Assigned to BICO GROUP AB reassignment BICO GROUP AB CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: CELLINK AB
Assigned to CELLINK BIOPRINTING AB reassignment CELLINK BIOPRINTING AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BICO GROUP AB
Assigned to CELLINK BIOPRINTING AB reassignment CELLINK BIOPRINTING AB ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BICO GROUP AB
Publication of US11931966B2 publication Critical patent/US11931966B2/en
Application granted granted Critical
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C64/00Additive manufacturing, i.e. manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3D printing, stereolithography or selective laser sintering
    • B29C64/30Auxiliary operations or equipment
    • B29C64/386Data acquisition or data processing for additive manufacturing
    • B29C64/393Data acquisition or data processing for additive manufacturing for controlling or regulating additive manufacturing processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/02Small extruding apparatus, e.g. handheld, toy or laboratory extruders
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/25Component parts, details or accessories; Auxiliary operations
    • B29C48/92Measuring, controlling or regulating
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C64/00Additive manufacturing, i.e. manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3D printing, stereolithography or selective laser sintering
    • B29C64/10Processes of additive manufacturing
    • B29C64/106Processes of additive manufacturing using only liquids or viscous materials, e.g. depositing a continuous bead of viscous material
    • B29C64/112Processes of additive manufacturing using only liquids or viscous materials, e.g. depositing a continuous bead of viscous material using individual droplets, e.g. from jetting heads
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B29WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29CSHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C64/00Additive manufacturing, i.e. manufacturing of three-dimensional [3D] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3D printing, stereolithography or selective laser sintering
    • B29C64/20Apparatus for additive manufacturing; Details thereof or accessories therefor
    • B29C64/205Means for applying layers
    • B29C64/209Heads; Nozzles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y10/00Processes of additive manufacturing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y30/00Apparatus for additive manufacturing; Details thereof or accessories therefor
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y50/00Data acquisition or data processing for additive manufacturing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y50/00Data acquisition or data processing for additive manufacturing
    • B33Y50/02Data acquisition or data processing for additive manufacturing for controlling or regulating additive manufacturing processes
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y70/00Materials specially adapted for additive manufacturing
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B33ADDITIVE MANUFACTURING TECHNOLOGY
    • B33YADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
    • B33Y70/00Materials specially adapted for additive manufacturing
    • B33Y70/10Composites of different types of material, e.g. mixtures of ceramics and polymers or mixtures of metals and biomaterials
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N3/00Computing arrangements based on biological models
    • G06N3/02Neural networks
    • G06N3/08Learning methods
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N5/00Computing arrangements using knowledge-based models
    • G06N5/01Dynamic search techniques; Heuristics; Dynamic trees; Branch-and-bound
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N20/00Machine learning
    • G06N20/10Machine learning using kernel methods, e.g. support vector machines [SVM]
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06NCOMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N7/00Computing arrangements based on specific mathematical models
    • G06N7/01Probabilistic graphical models, e.g. probabilistic networks

Definitions

  • the present invention relates to the fields of 3D printing and bioprinting. More particularly, embodiments of the present invention relate to optically-based systems and methods which allow for assessments of bioink printability.
  • a 3D bioprinter is a machine or device that spatially deposits, cross-links, or assembles biomaterials known as bioinks to fabricate tissue-like structures that are utilized in medical therapeutic, drug discovery, research, and tissue engineering fields.
  • Bioprinters utilize materials known as bioinks to assemble multilayered three-dimensional structures or single layered two-dimensional patterns via extruded filaments, deposited droplets, or controlled crosslinking.
  • Bioprinting utilizes 3D printing and 3D printing—like techniques to combine cells, growth factors, and biomaterials to fabricate constructs that maximally imitate natural tissue characteristics and can be utilized in applications such as drug evaluation and discovery, tissue and organ engineering, studying cells in a 3D environment, and recapitulating multifaceted native architectures.
  • bioinks Materials that are suitable for 3D bioprinting applications are distinct from traditional 3D printing materials. These materials, known as bioinks, can be defined by two qualities. The first is the ability to support and maintain cell viability during and after the printing process, the second is maintenance of structure and resulting filament characteristics after deposition and cross-linking (if applicable). As available bioinks increase there is a need for complementary techniques and metrics to validate a 3D bioprinted structure and bioinks.
  • Embodiments of the present invention provide systems and methods for optical assessments of bioink printability.
  • the systems and methods include the use of hardware such as bioprinter or 3D printer systems, optical imaging devices, and standardized or customizable optical targets to enable the evaluation of bioink printability.
  • the optical targets are developed and fabricated from 3D printable materials for the establishment of comparison and calibration standards based on “nozzle fidelic” or other materials such as those with well characterized thermosensitivity, cross-linking behavior, stability, or other relative properties.
  • the optical targets make it possible to rapidly compare and evaluate bioink printability and can be easily customized and tailored for specific applications.
  • FIG. 1 is a schematic drawing of a printhead of a 3D printer or bioprinter according to an embodiment.
  • FIG. 2 is a drawing of an ink/bioink pressure calibration process according to an embodiment.
  • FIG. 3 is a schematic drawing of an automatic feedback control according to an embodiment.
  • FIG. 4 is a flowchart of steps for an exemplary process according to an embodiment.
  • FIG. 5 is a flowchart of a method for ink/bioink characterization according to an embodiment.
  • FIG. 6 is a flowchart of a method for ink/bioink calibration according to an embodiment.
  • FIG. 7 is a flowchart of a printing process according to an embodiment.
  • Optical Imaging is the use of light as an investigational imaging technique for medical and other applications. Examples include optical microscopy, spectroscopy, endoscopy, scanning laser ophthalmoscopy, and optical coherence tomography. According to this disclosure, the optical imaging apparatus includes one or more sensors and/or cameras for capturing images and/or video.
  • Droplet is a structure that is formed when a material, for example, a bioink, is extruded at a single location on the print surface.
  • the printhead does not translate in the x-y plane (where the x-y plane is the print surface), only in the z-direction, if necessary.
  • the resultant shape is typically circular or eclipse in shape when observed from above with an eccentricity between 0 and 1, and a minimum volume of 1 nL.
  • a droplet can also be deposit through contactless bioprinting or printing techniques such as the use of an inkjet printing mechanism or an electrical field.
  • a printed filament is a structure that is formed when a bioink is extruded across the print surface where the printhead translates along waypoints to result in a non-enclosed structure.
  • the printhead translates in the x-y plane (where the x-y plane is the print surface), with the nozzle positioned above the surface in the z-axis at a height between 10% and 500% of the nozzle inner diameter.
  • a printed filament structure typically has a minimum total length to width ratio of 1 and a maximum of 100000.
  • Geometric structure is a structure that is formed when a bioink is extruded across the print surface during printhead translation along waypoints and intersects or contacts the existing structure to enclose an area.
  • the printhead translates in the x-y plane (where the x-y plane is the print surface), with the nozzle positioned above the surface in the z-axis at a height between 10% and 500% of the nozzle inner diameter.
  • These geometric structures have a minimum of 0 vertices and 1 edge and enclose an area. The angle between subsequent edges at vertices can range from 0.001 degree to 179.99 degrees.
  • An infill pattern is a structure that is formed when a bioink is extruded across a print surface during printhead translation along waypoints in a fashion to fill in a printed geometric shape.
  • the printhead translates in the x-y plane (where the x-y plane is the print surface), with the nozzle positioned above the surface in the z-axis at a height between 10% and 500% of the nozzle inner diameter.
  • the infill pattern typically provides structural support, porosity, or generates micro-architectures that mimic native tissue structure or serve as a framework for tissue regeneration.
  • the spacing between the centers of adjacent filaments can range from a distance equal to the filament diameter to 5 times, 10 times, or 100 times the filament diameter.
  • Infill pattern can also include multiple material or bioink types that are arranged or encapsulated within the broader structure.
  • Deposited filaments such as those composed of sacrificial materials such as PEO (poly(ethylene oxide)), PEG (poly(ethylene glycol)), Pluronics® (poloxamers), and/or gelatin based bioink, can be used.
  • Sacrificial materials which dissolve or are otherwise not permanent or present in the final structure are useful, for example, for creating void regions, conduits, and/or perfusable channels and can also be considered an infill pattern.
  • These sacrificial materials may comprise 0% to 100% of the infill pattern, such as from 5-90%, or 15-75%, or 30-60%, or 10-80%, or 20-50%, for example.
  • a multilayered structure is a structure that is generated when a bioink is extruded on top of a previously deposited structure.
  • the printhead translates in the x-y plane (where the x-y plane is the previously deposited structure), with the nozzle positioned above the previously deposited structure in the z-axis at a height between 10% and 500% of the nozzle inner diameter.
  • Droplets, printed filaments, geometric shapes, and infill patterns can all be printed on the previously printed layer.
  • the number of previously printed layers is a minimum of 1 to achieve the maximum build height set by the bioprinter system being utilized.
  • Bioink printability The overall quantification of the relationship between the resulting filament characteristics and the printing parameters is known as bioink printability.
  • the resulting characteristics of a bioink are highly dependent on both the bioink composition and the printing parameters utilized during the fabrication process. These defined metrics can be utilized to compare and contrast different types of bioinks and printing conditions of bioinks.
  • Printability metrics of bioinks can include the resultant filament thickness, uniformity, roughness, continuity, color, opacity, and geometry at intersections and other directional changes that is quantifiable during and after the printing process and directly related to the utilized printing parameters.
  • Printing parameters of bioinks include applied pressure, strain, force, or flow, translation rate, start delay, stop delay, overshoot, undershoot of the printhead during the printing process, temperature of the bioink, temperature of the print surface, material of the print surface, layer height, infill pattern and density, the nozzle diameter, nozzle shape, and nozzle material.
  • a nozzle fidelic material is a bioink that can generate a stable filament with a diameter between 100% and 125% of the nozzle inner diameter.
  • a bioink capable of producing a filament of 500 ⁇ m from a nozzle with a 400 ⁇ m inner diameter is considered a nozzle fidelic material for that particular nozzle and conditions.
  • Real-time mode In real-time mode, the system processes and compares the data captured by the optical imaging apparatus to the reference data already present in the system and/or the information provided by the user of the 3D bioprinter in actual time or within milliseconds of capturing the image and/or live video feed.
  • Layer-by-layer mode In layer-by-layer mode, the system processes and compares the data captured by the optical imaging apparatus to the reference data already present in the system and/or the information provided by the user of the 3D bioprinter after a layer of the 3D build has been printed.
  • a process algorithm is any algorithm or protocol that receives an image or video from the optical imaging apparatus and identifies a point of interest, isolates it, and quantifies various metrics.
  • a learning algorithm is any algorithm that receives data from or during a measurement and utilizes data from a broader dataset to automatically improve the existing print or future prints.
  • a database is a repository of data consisting of bioink printability and properties, results of previous prints, and previous print adjustments that can be accessed by and shared across individual bioprinter systems to provide reference points and aid in the development of process and/or learning algorithms.
  • Printing Instructions are computer code or computer-executable instructions which can include G-code files, STL files, text files, or manual inputs.
  • Microwell Plate A microwell plate is a flat plate with more than one well used as small test tubes. It is typically used in analytical research and clinical diagnostic testing laboratories.
  • Embodiments of the present invention provide systems and methods for optical assessments of bioink printability.
  • a 3D printer or bioprinter system is provided that includes a plurality of components that work in concert to optically characterize one or more printability metrics of the 3D printer or bioprinter.
  • 3D printer or bioprinter comprising one or more of the following:
  • one or more learning algorithms capable of modifying and adjusting printing instructions and/or parameters based on one or more printability metrics to achieve a second printed structure.
  • the 3D printer or bioprinter can include one or more additional components such as motors, printheads, print bed, substrates for printing, printed structures, cartridges, syringes, platforms, lasers, operating controls, power cables, and USB ports/connectors and/or cables.
  • additional components such as motors, printheads, print bed, substrates for printing, printed structures, cartridges, syringes, platforms, lasers, operating controls, power cables, and USB ports/connectors and/or cables.
  • the 3D printer or bioprinter is in communication with or integrated with a database where printability analysis can be shared and compared across batches and users.
  • the optical imaging apparatus includes one or more infrared, near-infrared, visible, or UV sensors or cameras.
  • the imaging apparatus can be capable of obtaining high definition (HD) images, such as HD digital images.
  • HD high definition
  • the imaging apparatus can be mounted to a printhead, whether a single-function or multi-function printhead.
  • the imaging apparatus can comprise an HD camera mounted to the side of one or more printhead that is or is not also capable of printing bioink.
  • the camera can be disposed in a position where the optical elements of the camera are oriented toward the print bed of the 3D printer or bioprinter, or other printing surface. In this manner, the camera can obtain still and/or video images of the print bed or printing surface and/or the structure being formed on the print bed or printing surface, before, during or after the printing.
  • the imaging apparatus is disposed on a printhead in a manner such that the imaging apparatus is positioned to the side, above, and/or below the nozzle of the printhead through which bionk is disposed during the printing process.
  • the still and/or video images captured by the camera can be transmitted back to a processing and/or control unit located inside and/or outside the 3D bioprinter.
  • one or more than one camera can be mounted in and/or on any part of the printhead.
  • the one or more printability metrics can be chosen from one or more of filament thickness, uniformity, roughness, continuity, color, opacity, and/or geometry at intersections and/or other directional changes.
  • the printing parameters can be chosen from one or more of applied pressure, strain, force, or flow, printhead translation rate, bioink temperature, bioink composition, print surface temperature, layer height, infill pattern and density, nozzle diameter, nozzle shape, and/or nozzle material.
  • a calibration process according to embodiments of the invention is shown in FIG. 2 .
  • the 3D printer or bioprinter is programmed to deposit a bioink under both variable and constant printing parameters. For this example, all parameters will be held constant with the exception of printing pressure and translation rate.
  • the user provides printing instructions or the 3D printer or bioprinter generates printing instructions from user input or an algorithm that varies a particular printing parameter.
  • the printing instructions deposit filaments that are generated from distinct parameters.
  • the bioprinter or 3D printer then utilizes the optical imaging apparatus to capture an image. These are then presented to the user and/or entered into a processing and/or learning algorithm for evaluation as a whole, which algorithm(s) then recommend optimal parameters for the desired resulting diameter or other characteristic.
  • the printed structure is or includes a droplet, a linear or curved filament, a geometric shape, an infill pattern, and/or multilayered structure deposited using a bioink.
  • the printed structured can serve as an optical or calibration target to allow rapid comparisons to known standard printable materials and/or internal controls.
  • the optical or calibration target can be or can include a non-thermoresponsive filament, a thermoresponsive filament, or both.
  • the optical or calibration target can be or can be comprised of “nozzle fidelic” printable materials, such as thermoplastics or silicone so the user can fabricate customizable printability targets.
  • suitable thermoplastics include polyethylene, polypropylene, polyvinyl chloride (PVC), and polystyrene.
  • the optical or calibration target can be or can include materials that exhibit a well characterized thermosensitivity as a calibration target which can be analyzed using software and thermal sensors or cameras such as infrared-detecting sensors and/or cameras.
  • the printability data generated from the calibration target using such materials can be used to calibrate the printing parameters and adjust the printing instructions, such as provided by G-code, to optimize printing.
  • printing instructions which include G-code files, STL files, text files, or manual inputs can be provided by the user or generated through software.
  • the optical imaging apparatus can be provided as an independent printhead that does not deposit bioink and/or the structure that is being analyzed. In embodiments, the optical imaging apparatus can be provided as an independent printhead that does deposit bioink and/or the structure that is being analyzed.
  • the optical imaging apparatus includes one or more cameras or video cameras attached to a printhead that is depositing the structure that is currently being imaged.
  • the optical imaging apparatus can comprise multiple cameras or video cameras disposed on one or more printheads (which may or may not be the printhead(s) depositing material for the structure that is being imaged or analyzed).
  • the optical imaging apparatus can include at least two cameras offset to capture stereographic images.
  • the camera, video camera, or multiple cameras or video cameras can be disposed on the same or different printheads or at another location within or in the proximity of the 3D printer or bioprinter.
  • the imaging apparatus can comprise one or more illumination source and/or one or more illumination source can be included with the 3D printer or bioprinter to provide illumination for the imaging apparatus.
  • the illumination source(s) can be mounted on one or more printheads of the 3D printer or bioprinter in a manner to provide light for imaging placement of bioink on a print bed.
  • the illumination source(s) can provide light having an illumination angle of up to 30 degrees, up to 45 degrees, up to 60 degrees, up to 90 degrees, up to 120 degrees, up to 180 degrees or more.
  • the illumination sources can provide any single or combination of light colors and wavelengths for the illumination of the sample and/or bioink filaments.
  • the illumination sources can be used to illuminate sample(s), microwell plate(s), 2D printed layer(s) and/or 3D printed structures.
  • the optical imaging apparatus is able to capture images or videos before, during, and/or after printing, such as in real-time during the printing.
  • the process or analysis algorithm receives and analyzes images or video captured from the imaging apparatus, which data and images can be captured and analyzed after printing all or some of the structure, such as in real-time.
  • the analysis algorithm can utilize information from visual sensors to identify, isolate, and/or quantify the characteristics of the deposited structure before, during, or after some or all of the printing process.
  • the process or analysis algorithm can also utilize information from visual sensors to identify, isolate, and/or quantify the characteristics of the deposited structure before, during, or after completion of one or more printed layer or each printed layer, such as in real-time.
  • the learning algorithm facilitates machine learning so that the 3D printer or bioprinter can quantify, compare, and/or adjust the printing instructions based on the measured printed structure characteristics in real-time or before or after the completion of a printed layer or each printed layer.
  • a better printed structure is generated by altering some, any and/or all of the printing parameters of the 3D printer or bioprinter in order to deposit ink, such as bioink, such as a filament or whole printed structure, that more closely resembles the structure defined by the user through the printing instructions.
  • the learning algorithm compares what is measured to what has previously been measured with other prints and adjusts the parameters respectively or makes recommendations on how to adjust the parameters.
  • the learning algorithm can also be used to recommend new ink/bioink compositions based on some or all the data that has been collected (big data analysis). Additionally, the learning algorithm can also be used to determine the ideal printability parameters of a bioink with an unknown composition or a new composition that has yet to be tested.
  • the learning algorithm can be a classification algorithm such as hierarchical clustering, k means clustering, linear discriminant analysis, logistic regression, support vector machines, k-nearest neighbor, recursive partitioning, decision trees, neural networks, Bayesian networks, and Hidden Markov models.
  • k means clustering, linear discriminant analysis, logistic regression, support vector machines, k-nearest neighbor, recursive partitioning, decision trees, neural networks, Bayesian networks, and Hidden Markov models.
  • the database integration permits the utilization of printability metrics from other users and/or the manufacturer.
  • the printability metrics can be obtained from an external database and/or the manufacturer, from an incorporated barcode, or from an RFID chip within the packaging of the 3D printer or bioprinter or parts thereof, such as a barcode on a bioink cartridge.
  • the 3D printer or bioprinter can be integrated with or incorporates clean chamber technology or a clean chamber housing which provides sterility during the printing process as described in International Patent Application Publication No. WO 2017/040675, US2010/0206224, 2017/0172765, 2015/0105891, 2009/003696, 2012/024675, RE43955, U.S. Pat. No. 7,894,921, WO2009/053100, U.S. Pat. Nos.
  • the 3D printer or bioprinter can utilize a cellulose nanofibrillar dispersion as bioink as described in United States Patent Application Publication No. 20170368225, incorporated by reference herein in its entirety.
  • Embodiments of the invention include methods of generating printing characteristics associated with various printing parameters for an ink or bioink.
  • the flowcharts provided in FIGS. 4 and 7 provide examples of such methods.
  • the user selects an ink or bioink and inputs parameters associated with the ink or bioink into the printing program, such as printing pressure, extrusion rate, translation rate, layer height, printhead temperature, printbed temperature, and/or type of ink/bioink.
  • printing parameters and other data can be imported from a cloud server or other external method.
  • the central processing unit (CPU) sends Gcode and parameters to the printheads.
  • the printheads fabricate a 3D structure from the ink or bioink according to the Gcode and/or other parameters if provided.
  • the imaging apparatus images the printed structure during and/or after the print and the image(s) are transferred to the CPU for analysis, for example, using processing and learning algorithms.
  • the CPU displays the results to the user and the inputs can be changed if desired.
  • Subsequent prints can be performed and/or the printing parameters and/or printing data can be transferred to a database for future use and quality control.
  • the user and/or the computer selects printing parameters.
  • the 3D structure is printed in accordance with instructions implementing the printing parameters.
  • the structure is imaged using a camera, such as an HD camera. Analysis of the printed structure is performed to determine characteristics of the printed structure. The characteristics of the printed structure are compared with standards and/or previous data obtained through prior printing processes.
  • the computer can recommend various changes to the printing parameters to obtain a printed structure that is closer in comparison with the standards and/or other previously obtained data.
  • the printing process can then be repeated and/or the printing parameters changed based on the analysis and then the printing process can be repeated until a desirable final printed structure is obtained.
  • Another embodiment comprises a method for assessing printability of a bioink.
  • the method can include any of the following steps:
  • the 3D printer or bioprinter can compare the printed bioink to previously tested inks or bioinks and/or batch standards, and physically calibration targets that contain premade structures with ‘ideal’ diameters and shapes.
  • one or more of the optical imaging, analysis, and/or adjustment of printing parameters and/or instructions can be repeated until a defined printed structure is achieved with satisfactory accuracy.
  • the selection of bioink can be from preset bioink profiles that are loaded by a user or from an external database.
  • the selection of printing parameters can be from a preset profile, loaded or adjusted by a user, or from an external database.
  • the selection of the printed structure can be from a preset profile, loaded or adjusted by the user, or from an external database.
  • the one or more algorithms can automatically modify and/or adjust the bioink profiles, printing parameters, and/or printed structure characteristics.
  • the algorithm(s) can compare the measured/imaged parameters to previously tested inks, the batch standards, and/or physical calibration targets that contain premade structures with ‘ideal’ diameters and shapes.
  • adjustment of the printing instructions can include the positioning of the optical apparatus to permit imaging of the deposited structure.
  • the analysis can be performed before, during, or after printing, such as in real-time, and the printing instructions are capable of being modified before, during, or after the print.
  • the results of the analysis can be compiled in a database where such results are utilized to refine subsequent analysis.
  • Another embodiment provides a method for calibration of a bioink on a 3D printer or bioprinter.
  • the method can include any of the following steps:
  • the surface includes a print surface or a separate surface within the 3D printer or bioprinter or inserted into the 3D printer or bioprinter.
  • the analyzing involves assessing one or more of filament thickness, uniformity, roughness, continuity, color, opacity, and/or geometry at intersections and/or other directional changes in comparison with the calibration target.
  • the printing parameters are chosen from one or more of applied pressure, strain, force, or flow, printhead translation rate, bioink temperature, bioink composition, print surface temperature, layer height, infill pattern and density, nozzle diameter, nozzle shape, and/or nozzle material.
  • the one or more calibration targets include patterned arrangements of droplets, filaments, geometric shapes, infill patterns, and/or multilayered structures.
  • the one or more calibration targets are fabricated and customized based on input of a user or designation of integrated software and algorithms of the 3D printer or bioprinter.
  • the separate surface includes one or more different materials including plastic, glass, hydrogel, or biomolecule coated surfaces to calibrate the one or more printing parameters on different surfaces.
  • the one or more calibration targets are fabricated based on previous printability metrics and analysis performed and recommended by learning algorithms to more rapidly test a bioink.
  • the calibration target may have lines with diameters of 200 ⁇ m, 400 ⁇ m, 600 ⁇ m, 800 ⁇ m, etc.
  • the user can quickly print a line, then compare the line to the targets.
  • the comparison may involve comparing the printed bioink to the calibration target to determine if the bioink is printed with the same height and shape as the calibration target. This allows the user to quickly figure out how the material is printing initially so when the algorithm begins to optimize it knows what range of possible printing parameters to start at based on previous data. For example, if a user desires to print a line that is 450 ⁇ m in diameter, the objective is 500 ⁇ m. So the user knows that whatever parameters are desired to be tested should be between the parameters just used to achieve a 450 um diameter line and the parameters observed in the past to achieve a 600 ⁇ m line.
  • the algorithm can be programmed to start homing down in that range.
  • the fabrication of the bioink structure occurs adjacent to or in proximity of the one or more calibration targets for rapid analysis.
  • one or more prefabricated calibration targets are provided to contain a range of filament diameters, heights, intersection angles along with geometric structures, and multilayered structures with various infill patterns and porosity.
  • the one or more printing parameters are stored within the 3D printer or bioprinter and in a database on a per batch basis and are capable of serving as a quality control comparison point.
  • the system can include a non-transitory computer storage media such as RAM which stores a set of computer-executable instructions (also referred to herein as computer-readable code, “code”, or software) for instructing the processor(s) to carry out any of the algorithms and methods described in this disclosure.
  • a “non-transitory computer-readable medium (or media)” may include any kind of computer memory, including magnetic storage media, optical storage media, nonvolatile memory storage media, and volatile memory.
  • Non-limiting examples of non-transitory computer-readable storage media include floppy disks, magnetic tape, conventional hard disks, CD-ROM, DVD-ROM, BLU-RAY, Flash ROM, memory cards, optical drives, solid state drives, flash drives, erasable programmable read only memory (EPROM), electrically erasable programmable read-only memory (EEPROM), non-volatile ROM, and RAM.
  • the non-transitory computer readable media can include one or more sets of computer-executable instructions for providing an operating system as well as for implementing the algorithms and methods of the invention.
  • the computer-executable instructions can be programmed in any suitable programming language, including JavaScript, C, C#, C++, Java, Python, Perl, Ruby, Swift, Visual Basic, and Objective C.
  • An example of a process algorithm may include the following steps. First a structure is deposited by a 3D printer system on a print surface. The parameters utilized to print the structure which may include applied pressure, strain, translation speed, nozzle shape, nozzle diameter, layer height, temperature of printhead and/or printbed can be recorded by the system. The structure is then imaged during or after the completion of the printing process. The image can be inputted into the process algorithm. The process algorithm filters out the background and isolates the region of interest. In this example, the region of interest may be a linear filament, but it can be any structure. After finding the region of interest, the application determines the boundaries of the filament or structure.
  • the data on the location of these boundaries is extracted and then processed to quantify characteristics of the filament or structure such as diameter, uniformity, thickness, etc.
  • This data is then presented to the user so the user can adjust the printing parameters based on the result and refine the printing process, if needed. Additionally, this data can be stored on the printer or uploaded to a database where it can refine other algorithms. See for example FIGS. 4 and 7 .
  • An example of a learning algorithm may include the following steps.
  • the learning algorithm is used to calibrate a bioink in real-time by comparing it to a standard and historical printing data. The user chooses the desired resulting structural characteristics. Based on previous data, the algorithm sets default printing parameters and then prints a structure. The algorithm then compares the characteristics of the resulting structure to the standard.
  • the standard could be the theoretical ideal printing result or a calibration target that has a predefined structure that the print wants to achieve.
  • the algorithm predicts how the printing parameters should be adjusted to achieve the desired characteristics. This process can be repeated until the printing parameters that are recommended provide a structure within an acceptable error of the target. See, for example, FIG.
  • the learning algorithm sets predicted printing parameters.
  • the user inserts an appropriate calibration target and Gcode is generated to print a structure onto the calibration target.
  • an image(s) of the printed structure is captured using a camera printhead and the image is analyzed using one or more process algorithm according to the invention.
  • one or more learning algorithms can be used to compare the analyzed structure to reference data, such as previous print data and/or stored data relating to other prints.
  • New printing parameters can be set and associated Gcode provided for performing the printing using the new printing parameters.
  • the printing and analysis steps can be repeated any number of times until the desired/target filament diameter is obtained.
  • the printing parameters can be output to a database to be used later as a reference for parameters recommended and/or suggested for obtaining the desired/target filament diameter for that bioink.
  • a learning algorithm may include the following process.
  • the learning algorithm is used to preset printing parameters based on the composition of the bioink that is provided by the user and/or other source.
  • the user inputs data that relates to the composition of the bioink they want to print with, if known.
  • the inputted data can include chemical base, concentration, composition, and/or type of material.
  • the learning algorithm compares this bioink to previous bioink characteristics obtained, for example, from a reference source and/or previous prints and gives recommended printability data for the bioink. Gcode can be generated to change printing parameters for evaluation.
  • the bioink calibration process can follow the steps in the above learning algorithm example to print a 3D structure, image the structure, analyze features of the structure, and compare the structure with other reference structures and/or previously printed structures.
  • the algorithm can analyze one or more or all the printability data for one or more or all the bioinks as a whole and make recommendations for new bioinks or improvements in currently used bioinks regarding printability and composition. See, for example, FIG. 5

Landscapes

  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Physics & Mathematics (AREA)
  • Mechanical Engineering (AREA)
  • Optics & Photonics (AREA)
  • Theoretical Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Mathematical Physics (AREA)
  • Software Systems (AREA)
  • General Physics & Mathematics (AREA)
  • Computing Systems (AREA)
  • Evolutionary Computation (AREA)
  • Data Mining & Analysis (AREA)
  • Computational Linguistics (AREA)
  • Artificial Intelligence (AREA)
  • Health & Medical Sciences (AREA)
  • Ceramic Engineering (AREA)
  • Civil Engineering (AREA)
  • Composite Materials (AREA)
  • Structural Engineering (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Clinical Laboratory Science (AREA)

Abstract

Systems and methods for optical assessments of bioink printability are described. The systems and methods include the use of hardware, software and optical targets to aid in the evaluation of bioink printability. The optical targets are developed and fabricated from 3D printable materials determined to be “nozzle fidelic” and/or materials that possess well characterized thermosensitivity. The optical targets make it possible to rapidly compare and evaluate bioink printability and can be easily customized and tailored for specific applications.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS
    • The present application is a National Stage application under 35 U.S.C. 371 of International Application No. PCT/IB2019/000215, filed Jan. 25, 2019, which application relies on the disclosure of and claims priority to and the benefit of the filing date of U.S. Provisional Application No. 62/622,650 filed Jan. 26, 2018, the disclosures of which are hereby incorporated by reference in their entireties.
BACKGROUND OF THE INVENTION Field of the Invention
The present invention relates to the fields of 3D printing and bioprinting. More particularly, embodiments of the present invention relate to optically-based systems and methods which allow for assessments of bioink printability.
Description of Related Art
A 3D bioprinter is a machine or device that spatially deposits, cross-links, or assembles biomaterials known as bioinks to fabricate tissue-like structures that are utilized in medical therapeutic, drug discovery, research, and tissue engineering fields. Bioprinters utilize materials known as bioinks to assemble multilayered three-dimensional structures or single layered two-dimensional patterns via extruded filaments, deposited droplets, or controlled crosslinking. Bioprinting utilizes 3D printing and 3D printing—like techniques to combine cells, growth factors, and biomaterials to fabricate constructs that maximally imitate natural tissue characteristics and can be utilized in applications such as drug evaluation and discovery, tissue and organ engineering, studying cells in a 3D environment, and recapitulating multifaceted native architectures.
The resulting characteristics of a bioink are highly dependent on both the bioink composition and the printing parameters utilized during the fabrication process. The overall quantification of the relationship between the resulting filament characteristics and the printing parameters is known as the printability of the bioink. Materials that are suitable for 3D bioprinting applications are distinct from traditional 3D printing materials. These materials, known as bioinks, can be defined by two qualities. The first is the ability to support and maintain cell viability during and after the printing process, the second is maintenance of structure and resulting filament characteristics after deposition and cross-linking (if applicable). As available bioinks increase there is a need for complementary techniques and metrics to validate a 3D bioprinted structure and bioinks.
SUMMARY OF THE INVENTION
Embodiments of the present invention provide systems and methods for optical assessments of bioink printability. The systems and methods include the use of hardware such as bioprinter or 3D printer systems, optical imaging devices, and standardized or customizable optical targets to enable the evaluation of bioink printability. The optical targets are developed and fabricated from 3D printable materials for the establishment of comparison and calibration standards based on “nozzle fidelic” or other materials such as those with well characterized thermosensitivity, cross-linking behavior, stability, or other relative properties. The optical targets make it possible to rapidly compare and evaluate bioink printability and can be easily customized and tailored for specific applications.
Additional embodiments and their features will be elaborated in the foregoing Detailed Description.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a schematic drawing of a printhead of a 3D printer or bioprinter according to an embodiment.
FIG. 2 is a drawing of an ink/bioink pressure calibration process according to an embodiment.
FIG. 3 is a schematic drawing of an automatic feedback control according to an embodiment.
FIG. 4 is a flowchart of steps for an exemplary process according to an embodiment.
FIG. 5 is a flowchart of a method for ink/bioink characterization according to an embodiment.
FIG. 6 is a flowchart of a method for ink/bioink calibration according to an embodiment.
FIG. 7 is a flowchart of a printing process according to an embodiment.
DETAILED DESCRIPTION OF VARIOUS EMBODIMENTS OF THE INVENTION
Reference will now be made in detail to various exemplary embodiments of the invention. It is to be understood that the following discussion of exemplary embodiments is not intended as a limitation on the invention. Rather, the following discussion is provided to give the reader a more detailed understanding of certain aspects and features of the invention.
Definitions:
The following definitions are provided to facilitate understanding of certain terms provided in this specification. For other terms not defined herein, the ordinary meaning as recognized by an ordinarily-skilled artisan should be applied.
Optical Imaging Apparatus: Optical imaging is the use of light as an investigational imaging technique for medical and other applications. Examples include optical microscopy, spectroscopy, endoscopy, scanning laser ophthalmoscopy, and optical coherence tomography. According to this disclosure, the optical imaging apparatus includes one or more sensors and/or cameras for capturing images and/or video.
Droplet: A droplet is a structure that is formed when a material, for example, a bioink, is extruded at a single location on the print surface. The printhead does not translate in the x-y plane (where the x-y plane is the print surface), only in the z-direction, if necessary. Depending on the composition of the bioink, the resultant shape is typically circular or eclipse in shape when observed from above with an eccentricity between 0 and 1, and a minimum volume of 1 nL. A droplet can also be deposit through contactless bioprinting or printing techniques such as the use of an inkjet printing mechanism or an electrical field.
Printed filament: A printed filament is a structure that is formed when a bioink is extruded across the print surface where the printhead translates along waypoints to result in a non-enclosed structure. The printhead translates in the x-y plane (where the x-y plane is the print surface), with the nozzle positioned above the surface in the z-axis at a height between 10% and 500% of the nozzle inner diameter. A printed filament structure typically has a minimum total length to width ratio of 1 and a maximum of 100000.
Geometric structure: A geometric structure is a structure that is formed when a bioink is extruded across the print surface during printhead translation along waypoints and intersects or contacts the existing structure to enclose an area. The printhead translates in the x-y plane (where the x-y plane is the print surface), with the nozzle positioned above the surface in the z-axis at a height between 10% and 500% of the nozzle inner diameter. These geometric structures have a minimum of 0 vertices and 1 edge and enclose an area. The angle between subsequent edges at vertices can range from 0.001 degree to 179.99 degrees.
Infill Pattern: An infill pattern is a structure that is formed when a bioink is extruded across a print surface during printhead translation along waypoints in a fashion to fill in a printed geometric shape. The printhead translates in the x-y plane (where the x-y plane is the print surface), with the nozzle positioned above the surface in the z-axis at a height between 10% and 500% of the nozzle inner diameter. The infill pattern typically provides structural support, porosity, or generates micro-architectures that mimic native tissue structure or serve as a framework for tissue regeneration. The spacing between the centers of adjacent filaments (x-y positioning on the print surface) can range from a distance equal to the filament diameter to 5 times, 10 times, or 100 times the filament diameter. For example, for a 150 μm filament, the spacing between the centers of adjacent filaments can be 150 μm, up to 0.75 mm, up to 1.5 mm, or up to 15 mm. Infill pattern can also include multiple material or bioink types that are arranged or encapsulated within the broader structure. Deposited filaments such as those composed of sacrificial materials such as PEO (poly(ethylene oxide)), PEG (poly(ethylene glycol)), Pluronics® (poloxamers), and/or gelatin based bioink, can be used. Sacrificial materials which dissolve or are otherwise not permanent or present in the final structure are useful, for example, for creating void regions, conduits, and/or perfusable channels and can also be considered an infill pattern. These sacrificial materials may comprise 0% to 100% of the infill pattern, such as from 5-90%, or 15-75%, or 30-60%, or 10-80%, or 20-50%, for example.
Multilayered Structure: A multilayered structure is a structure that is generated when a bioink is extruded on top of a previously deposited structure. The printhead translates in the x-y plane (where the x-y plane is the previously deposited structure), with the nozzle positioned above the previously deposited structure in the z-axis at a height between 10% and 500% of the nozzle inner diameter. Droplets, printed filaments, geometric shapes, and infill patterns can all be printed on the previously printed layer. The number of previously printed layers is a minimum of 1 to achieve the maximum build height set by the bioprinter system being utilized.
Bioink printability: The overall quantification of the relationship between the resulting filament characteristics and the printing parameters is known as bioink printability. The resulting characteristics of a bioink are highly dependent on both the bioink composition and the printing parameters utilized during the fabrication process. These defined metrics can be utilized to compare and contrast different types of bioinks and printing conditions of bioinks.
Printability metrics of bioinks: Printability metrics of bioinks can include the resultant filament thickness, uniformity, roughness, continuity, color, opacity, and geometry at intersections and other directional changes that is quantifiable during and after the printing process and directly related to the utilized printing parameters.
Printing parameters of bioinks: Printing parameters of bioinks include applied pressure, strain, force, or flow, translation rate, start delay, stop delay, overshoot, undershoot of the printhead during the printing process, temperature of the bioink, temperature of the print surface, material of the print surface, layer height, infill pattern and density, the nozzle diameter, nozzle shape, and nozzle material.
Nozzle fidelic: A nozzle fidelic material is a bioink that can generate a stable filament with a diameter between 100% and 125% of the nozzle inner diameter. For example, a bioink capable of producing a filament of 500 μm from a nozzle with a 400 μm inner diameter is considered a nozzle fidelic material for that particular nozzle and conditions.
Real-time mode: In real-time mode, the system processes and compares the data captured by the optical imaging apparatus to the reference data already present in the system and/or the information provided by the user of the 3D bioprinter in actual time or within milliseconds of capturing the image and/or live video feed.
Layer-by-layer mode: In layer-by-layer mode, the system processes and compares the data captured by the optical imaging apparatus to the reference data already present in the system and/or the information provided by the user of the 3D bioprinter after a layer of the 3D build has been printed.
Process Algorithms: A process algorithm is any algorithm or protocol that receives an image or video from the optical imaging apparatus and identifies a point of interest, isolates it, and quantifies various metrics.
Learning Algorithms: A learning algorithm is any algorithm that receives data from or during a measurement and utilizes data from a broader dataset to automatically improve the existing print or future prints.
Database: A database is a repository of data consisting of bioink printability and properties, results of previous prints, and previous print adjustments that can be accessed by and shared across individual bioprinter systems to provide reference points and aid in the development of process and/or learning algorithms.
Printing Instructions: Printing instructions are computer code or computer-executable instructions which can include G-code files, STL files, text files, or manual inputs.
Microwell Plate: A microwell plate is a flat plate with more than one well used as small test tubes. It is typically used in analytical research and clinical diagnostic testing laboratories.
Embodiments of the present invention provide systems and methods for optical assessments of bioink printability. In one embodiment, a 3D printer or bioprinter system is provided that includes a plurality of components that work in concert to optically characterize one or more printability metrics of the 3D printer or bioprinter.
Provided is a 3D printer or bioprinter comprising one or more of the following:
(a) one or more optical imaging apparatus;
(b) one or more control element;
(c) one or more processor and communication interface operably connecting and capable of communicating printability data from the one or more optical imaging apparatus to the one or more control element; and
(d) a non-transitory computer-readable storage media comprising:
(1) one or more process algorithms capable of analysis of the printability data from one or more images and/or video of a first printed structure produced by the 3D printer or bioprinter; and
(2) optionally, one or more learning algorithms capable of modifying and adjusting printing instructions and/or parameters based on one or more printability metrics to achieve a second printed structure.
According to embodiments, the 3D printer or bioprinter can include one or more additional components such as motors, printheads, print bed, substrates for printing, printed structures, cartridges, syringes, platforms, lasers, operating controls, power cables, and USB ports/connectors and/or cables.
According to embodiments, the 3D printer or bioprinter is in communication with or integrated with a database where printability analysis can be shared and compared across batches and users.
According to embodiments, the optical imaging apparatus includes one or more infrared, near-infrared, visible, or UV sensors or cameras. The imaging apparatus can be capable of obtaining high definition (HD) images, such as HD digital images.
In embodiments, the imaging apparatus can be mounted to a printhead, whether a single-function or multi-function printhead. As shown in FIG. 1 , the imaging apparatus can comprise an HD camera mounted to the side of one or more printhead that is or is not also capable of printing bioink. The camera can be disposed in a position where the optical elements of the camera are oriented toward the print bed of the 3D printer or bioprinter, or other printing surface. In this manner, the camera can obtain still and/or video images of the print bed or printing surface and/or the structure being formed on the print bed or printing surface, before, during or after the printing. In embodiments, the imaging apparatus is disposed on a printhead in a manner such that the imaging apparatus is positioned to the side, above, and/or below the nozzle of the printhead through which bionk is disposed during the printing process. The still and/or video images captured by the camera can be transmitted back to a processing and/or control unit located inside and/or outside the 3D bioprinter. In principle, one or more than one camera can be mounted in and/or on any part of the printhead.
According to embodiments, the one or more printability metrics can be chosen from one or more of filament thickness, uniformity, roughness, continuity, color, opacity, and/or geometry at intersections and/or other directional changes.
According to embodiments, the printing parameters can be chosen from one or more of applied pressure, strain, force, or flow, printhead translation rate, bioink temperature, bioink composition, print surface temperature, layer height, infill pattern and density, nozzle diameter, nozzle shape, and/or nozzle material.
A calibration process according to embodiments of the invention is shown in FIG. 2 . The 3D printer or bioprinter is programmed to deposit a bioink under both variable and constant printing parameters. For this example, all parameters will be held constant with the exception of printing pressure and translation rate. The user provides printing instructions or the 3D printer or bioprinter generates printing instructions from user input or an algorithm that varies a particular printing parameter. The printing instructions deposit filaments that are generated from distinct parameters. The bioprinter or 3D printer then utilizes the optical imaging apparatus to capture an image. These are then presented to the user and/or entered into a processing and/or learning algorithm for evaluation as a whole, which algorithm(s) then recommend optimal parameters for the desired resulting diameter or other characteristic.
According to embodiments, the printed structure is or includes a droplet, a linear or curved filament, a geometric shape, an infill pattern, and/or multilayered structure deposited using a bioink. In combination with the printer elements, the printed structured can serve as an optical or calibration target to allow rapid comparisons to known standard printable materials and/or internal controls.
For example, the optical or calibration target can be or can include a non-thermoresponsive filament, a thermoresponsive filament, or both. In addition or alternatively, the optical or calibration target can be or can be comprised of “nozzle fidelic” printable materials, such as thermoplastics or silicone so the user can fabricate customizable printability targets. Examples of suitable thermoplastics include polyethylene, polypropylene, polyvinyl chloride (PVC), and polystyrene. Further, the optical or calibration target can be or can include materials that exhibit a well characterized thermosensitivity as a calibration target which can be analyzed using software and thermal sensors or cameras such as infrared-detecting sensors and/or cameras. Still further, the printability data generated from the calibration target using such materials can be used to calibrate the printing parameters and adjust the printing instructions, such as provided by G-code, to optimize printing.
According to embodiments, printing instructions which include G-code files, STL files, text files, or manual inputs can be provided by the user or generated through software.
According to embodiments, the optical imaging apparatus can be provided as an independent printhead that does not deposit bioink and/or the structure that is being analyzed. In embodiments, the optical imaging apparatus can be provided as an independent printhead that does deposit bioink and/or the structure that is being analyzed.
According to embodiments, the optical imaging apparatus includes one or more cameras or video cameras attached to a printhead that is depositing the structure that is currently being imaged. In embodiments, the optical imaging apparatus can comprise multiple cameras or video cameras disposed on one or more printheads (which may or may not be the printhead(s) depositing material for the structure that is being imaged or analyzed). For example, the optical imaging apparatus can include at least two cameras offset to capture stereographic images. The camera, video camera, or multiple cameras or video cameras can be disposed on the same or different printheads or at another location within or in the proximity of the 3D printer or bioprinter. The imaging apparatus can comprise one or more illumination source and/or one or more illumination source can be included with the 3D printer or bioprinter to provide illumination for the imaging apparatus. As shown in FIG. 3 , the illumination source(s), such as a light source, can be mounted on one or more printheads of the 3D printer or bioprinter in a manner to provide light for imaging placement of bioink on a print bed. In embodiments, the illumination source(s) can provide light having an illumination angle of up to 30 degrees, up to 45 degrees, up to 60 degrees, up to 90 degrees, up to 120 degrees, up to 180 degrees or more. In addition, the illumination sources can provide any single or combination of light colors and wavelengths for the illumination of the sample and/or bioink filaments. The illumination sources can be used to illuminate sample(s), microwell plate(s), 2D printed layer(s) and/or 3D printed structures.
According to embodiments, the optical imaging apparatus is able to capture images or videos before, during, and/or after printing, such as in real-time during the printing.
According to embodiments, the process or analysis algorithm receives and analyzes images or video captured from the imaging apparatus, which data and images can be captured and analyzed after printing all or some of the structure, such as in real-time. The analysis algorithm can utilize information from visual sensors to identify, isolate, and/or quantify the characteristics of the deposited structure before, during, or after some or all of the printing process. The process or analysis algorithm can also utilize information from visual sensors to identify, isolate, and/or quantify the characteristics of the deposited structure before, during, or after completion of one or more printed layer or each printed layer, such as in real-time.
According to embodiments, the learning algorithm facilitates machine learning so that the 3D printer or bioprinter can quantify, compare, and/or adjust the printing instructions based on the measured printed structure characteristics in real-time or before or after the completion of a printed layer or each printed layer. As a result, a better printed structure is generated by altering some, any and/or all of the printing parameters of the 3D printer or bioprinter in order to deposit ink, such as bioink, such as a filament or whole printed structure, that more closely resembles the structure defined by the user through the printing instructions.
In embodiments, the learning algorithm compares what is measured to what has previously been measured with other prints and adjusts the parameters respectively or makes recommendations on how to adjust the parameters. The learning algorithm can also be used to recommend new ink/bioink compositions based on some or all the data that has been collected (big data analysis). Additionally, the learning algorithm can also be used to determine the ideal printability parameters of a bioink with an unknown composition or a new composition that has yet to be tested.
According to embodiments, the learning algorithm can be a classification algorithm such as hierarchical clustering, k means clustering, linear discriminant analysis, logistic regression, support vector machines, k-nearest neighbor, recursive partitioning, decision trees, neural networks, Bayesian networks, and Hidden Markov models.
According to embodiments, the database integration permits the utilization of printability metrics from other users and/or the manufacturer. The printability metrics can be obtained from an external database and/or the manufacturer, from an incorporated barcode, or from an RFID chip within the packaging of the 3D printer or bioprinter or parts thereof, such as a barcode on a bioink cartridge.
According to embodiments, the 3D printer or bioprinter can be integrated with or incorporates clean chamber technology or a clean chamber housing which provides sterility during the printing process as described in International Patent Application Publication No. WO 2017/040675, US2010/0206224, 2017/0172765, 2015/0105891, 2009/003696, 2012/024675, RE43955, U.S. Pat. No. 7,894,921, WO2009/053100, U.S. Pat. Nos. 7,892,474, 8,394,313, 7,783,371, 7,636,610, 7,195,472, 7,052,263, 6,942,830, WO2008/055533, EP1732746, US2017/0225393, US2017/0100899, US2017/0080641, US2015/0246482, US2015/0102351, U.S. Pat. No. 9,073,261, each incorporated by reference herein in their entireties.
According to embodiments, the 3D printer or bioprinter can utilize a cellulose nanofibrillar dispersion as bioink as described in United States Patent Application Publication No. 20170368225, incorporated by reference herein in its entirety.
Embodiments of the invention include methods of generating printing characteristics associated with various printing parameters for an ink or bioink. The flowcharts provided in FIGS. 4 and 7 provide examples of such methods. As shown in FIG. 4 , the user selects an ink or bioink and inputs parameters associated with the ink or bioink into the printing program, such as printing pressure, extrusion rate, translation rate, layer height, printhead temperature, printbed temperature, and/or type of ink/bioink. Additionally or alternatively, printing parameters and other data can be imported from a cloud server or other external method. The central processing unit (CPU) sends Gcode and parameters to the printheads. The printheads fabricate a 3D structure from the ink or bioink according to the Gcode and/or other parameters if provided. The imaging apparatus images the printed structure during and/or after the print and the image(s) are transferred to the CPU for analysis, for example, using processing and learning algorithms. The CPU displays the results to the user and the inputs can be changed if desired. Subsequent prints can be performed and/or the printing parameters and/or printing data can be transferred to a database for future use and quality control. As shown in FIG. 7 , the user and/or the computer selects printing parameters. The 3D structure is printed in accordance with instructions implementing the printing parameters. The structure is imaged using a camera, such as an HD camera. Analysis of the printed structure is performed to determine characteristics of the printed structure. The characteristics of the printed structure are compared with standards and/or previous data obtained through prior printing processes. The computer can recommend various changes to the printing parameters to obtain a printed structure that is closer in comparison with the standards and/or other previously obtained data. The printing process can then be repeated and/or the printing parameters changed based on the analysis and then the printing process can be repeated until a desirable final printed structure is obtained.
Another embodiment comprises a method for assessing printability of a bioink. The method can include any of the following steps:
    • (a) selecting one or more bioink, one or more printing parameters, and one or more printed structure characteristics;
    • (b) depositing the one or more bioink based on the selecting of the one or more bioink, the one or more printing parameters, and the one or more printed structure characteristics to create a first deposited structure;
    • (c) imaging the first deposited structure by one or more optical imaging apparatus to provide an optical image of the first deposited structure;
    • (d) analyzing the optical image by way of one or more algorithms;
    • (e) adjusting the printing parameters based on the analysis; and
    • (f) depositing a second deposited structure based on the adjusting.
In assessing printability of bioinks, the 3D printer or bioprinter can compare the printed bioink to previously tested inks or bioinks and/or batch standards, and physically calibration targets that contain premade structures with ‘ideal’ diameters and shapes.
According to embodiments, one or more of the optical imaging, analysis, and/or adjustment of printing parameters and/or instructions can be repeated until a defined printed structure is achieved with satisfactory accuracy.
According to embodiments, the selection of bioink can be from preset bioink profiles that are loaded by a user or from an external database.
According to embodiments, the selection of printing parameters can be from a preset profile, loaded or adjusted by a user, or from an external database.
According to embodiments, the selection of the printed structure can be from a preset profile, loaded or adjusted by the user, or from an external database.
According to embodiments, the one or more algorithms can automatically modify and/or adjust the bioink profiles, printing parameters, and/or printed structure characteristics.
In embodiments, the algorithm(s) can compare the measured/imaged parameters to previously tested inks, the batch standards, and/or physical calibration targets that contain premade structures with ‘ideal’ diameters and shapes.
According to embodiments, adjustment of the printing instructions can include the positioning of the optical apparatus to permit imaging of the deposited structure.
According to embodiments, the analysis can be performed before, during, or after printing, such as in real-time, and the printing instructions are capable of being modified before, during, or after the print.
According to embodiments, the results of the analysis can be compiled in a database where such results are utilized to refine subsequent analysis.
Another embodiment provides a method for calibration of a bioink on a 3D printer or bioprinter. The method can include any of the following steps:
    • (a) providing a calibration target on a surface or fabricating a calibration target on a surface using a 3D printer or bioprinter;
    • (b) fabricating a bioink structure;
    • (c) imaging and preparing an image of the bioink structure and the calibration target;
    • (d) analyzing the image of the bioink structure and the calibration target by way of one or more algorithms; and
    • (e) adjusting one or more printing parameters based on the analyzing.
According to embodiments, the surface includes a print surface or a separate surface within the 3D printer or bioprinter or inserted into the 3D printer or bioprinter.
According to embodiments, the analyzing involves assessing one or more of filament thickness, uniformity, roughness, continuity, color, opacity, and/or geometry at intersections and/or other directional changes in comparison with the calibration target.
According to embodiments, the printing parameters are chosen from one or more of applied pressure, strain, force, or flow, printhead translation rate, bioink temperature, bioink composition, print surface temperature, layer height, infill pattern and density, nozzle diameter, nozzle shape, and/or nozzle material.
According to embodiments, the one or more calibration targets include patterned arrangements of droplets, filaments, geometric shapes, infill patterns, and/or multilayered structures.
According to embodiments, the one or more calibration targets are fabricated and customized based on input of a user or designation of integrated software and algorithms of the 3D printer or bioprinter.
According to embodiments, the separate surface includes one or more different materials including plastic, glass, hydrogel, or biomolecule coated surfaces to calibrate the one or more printing parameters on different surfaces.
According to embodiments, the one or more calibration targets are fabricated based on previous printability metrics and analysis performed and recommended by learning algorithms to more rapidly test a bioink.
For example, using a calibration target is a quick way to compare a filament or shape with an ideal filament or shape. In one iteration, the calibration target may have lines with diameters of 200 μm, 400 μm, 600 μm, 800 μm, etc. The user can quickly print a line, then compare the line to the targets. The comparison, for example, may involve comparing the printed bioink to the calibration target to determine if the bioink is printed with the same height and shape as the calibration target. This allows the user to quickly figure out how the material is printing initially so when the algorithm begins to optimize it knows what range of possible printing parameters to start at based on previous data. For example, if a user desires to print a line that is 450 μm in diameter, the objective is 500 μm. So the user knows that whatever parameters are desired to be tested should be between the parameters just used to achieve a 450 um diameter line and the parameters observed in the past to achieve a 600 μm line. The algorithm can be programmed to start homing down in that range.
According to embodiments, the fabrication of the bioink structure occurs adjacent to or in proximity of the one or more calibration targets for rapid analysis.
According to embodiments, one or more prefabricated calibration targets are provided to contain a range of filament diameters, heights, intersection angles along with geometric structures, and multilayered structures with various infill patterns and porosity.
According to embodiments, the one or more printing parameters are stored within the 3D printer or bioprinter and in a database on a per batch basis and are capable of serving as a quality control comparison point.
According to embodiments, the system can include a non-transitory computer storage media such as RAM which stores a set of computer-executable instructions (also referred to herein as computer-readable code, “code”, or software) for instructing the processor(s) to carry out any of the algorithms and methods described in this disclosure. As used in the context of this specification, a “non-transitory computer-readable medium (or media)” may include any kind of computer memory, including magnetic storage media, optical storage media, nonvolatile memory storage media, and volatile memory. Non-limiting examples of non-transitory computer-readable storage media include floppy disks, magnetic tape, conventional hard disks, CD-ROM, DVD-ROM, BLU-RAY, Flash ROM, memory cards, optical drives, solid state drives, flash drives, erasable programmable read only memory (EPROM), electrically erasable programmable read-only memory (EEPROM), non-volatile ROM, and RAM. The non-transitory computer readable media can include one or more sets of computer-executable instructions for providing an operating system as well as for implementing the algorithms and methods of the invention. The computer-executable instructions can be programmed in any suitable programming language, including JavaScript, C, C#, C++, Java, Python, Perl, Ruby, Swift, Visual Basic, and Objective C.
EXAMPLES
An example of a process algorithm may include the following steps. First a structure is deposited by a 3D printer system on a print surface. The parameters utilized to print the structure which may include applied pressure, strain, translation speed, nozzle shape, nozzle diameter, layer height, temperature of printhead and/or printbed can be recorded by the system. The structure is then imaged during or after the completion of the printing process. The image can be inputted into the process algorithm. The process algorithm filters out the background and isolates the region of interest. In this example, the region of interest may be a linear filament, but it can be any structure. After finding the region of interest, the application determines the boundaries of the filament or structure. The data on the location of these boundaries is extracted and then processed to quantify characteristics of the filament or structure such as diameter, uniformity, thickness, etc. This data is then presented to the user so the user can adjust the printing parameters based on the result and refine the printing process, if needed. Additionally, this data can be stored on the printer or uploaded to a database where it can refine other algorithms. See for example FIGS. 4 and 7 .
An example of a learning algorithm may include the following steps. In this example, the learning algorithm is used to calibrate a bioink in real-time by comparing it to a standard and historical printing data. The user chooses the desired resulting structural characteristics. Based on previous data, the algorithm sets default printing parameters and then prints a structure. The algorithm then compares the characteristics of the resulting structure to the standard. The standard could be the theoretical ideal printing result or a calibration target that has a predefined structure that the print wants to achieve. Based on previous prints during this process, the current printing parameters, and/or the bioink composition, the algorithm predicts how the printing parameters should be adjusted to achieve the desired characteristics. This process can be repeated until the printing parameters that are recommended provide a structure within an acceptable error of the target. See, for example, FIG. 6 , where a user inserts a bioink whose parameters will be calibrated, and the desired filament diameter is set by the user. The learning algorithm sets predicted printing parameters. The user inserts an appropriate calibration target and Gcode is generated to print a structure onto the calibration target. Then an image(s) of the printed structure is captured using a camera printhead and the image is analyzed using one or more process algorithm according to the invention. Additionally, one or more learning algorithms can be used to compare the analyzed structure to reference data, such as previous print data and/or stored data relating to other prints. New printing parameters can be set and associated Gcode provided for performing the printing using the new printing parameters. The printing and analysis steps can be repeated any number of times until the desired/target filament diameter is obtained. The printing parameters can be output to a database to be used later as a reference for parameters recommended and/or suggested for obtaining the desired/target filament diameter for that bioink.
Another example of a learning algorithm may include the following process. In this example, the learning algorithm is used to preset printing parameters based on the composition of the bioink that is provided by the user and/or other source. The user inputs data that relates to the composition of the bioink they want to print with, if known. The inputted data can include chemical base, concentration, composition, and/or type of material. The learning algorithm compares this bioink to previous bioink characteristics obtained, for example, from a reference source and/or previous prints and gives recommended printability data for the bioink. Gcode can be generated to change printing parameters for evaluation. The bioink calibration process can follow the steps in the above learning algorithm example to print a 3D structure, image the structure, analyze features of the structure, and compare the structure with other reference structures and/or previously printed structures. Alternatively, the algorithm can analyze one or more or all the printability data for one or more or all the bioinks as a whole and make recommendations for new bioinks or improvements in currently used bioinks regarding printability and composition. See, for example, FIG. 5 .
The present invention has been described with reference to particular embodiments having various features. In light of the disclosure provided above, it will be apparent to those skilled in the art that various modifications and variations can be made in the practice of the present invention without departing from the scope or spirit of the invention. One skilled in the art will recognize that the disclosed features may be used singularly, in any combination, or omitted based on the requirements and specifications of a given application or design. When an embodiment refers to “comprising” certain features, it is to be understood that the embodiments can alternatively “consist of” or “consist essentially of” any one or more of the features. Any of the methods disclosed herein can be used with any of the systems or devices disclosed herein or with any other systems or devices. Likewise, any of the disclosed systems or devices can be used with any of the methods disclosed herein or with any other methods. Other embodiments of the invention will be apparent to those skilled in the art from consideration of the specification and practice of the invention.
It is noted in particular that where a range of values is provided in this specification, each value between the upper and lower limits of that range is also specifically disclosed. The upper and lower limits of these smaller ranges may independently be included or excluded in the range as well. The singular forms “a,” “an,” and “the” include plural referents unless the context clearly dictates otherwise. It is intended that the specification and examples be considered as exemplary in nature and that variations that do not depart from the essence of the invention fall within the scope of the invention. Further, all of the references cited in this disclosure are each individually incorporated by reference herein in their entireties and as such are intended to provide an efficient way of supplementing the enabling disclosure of this invention as well as provide background detailing the level of ordinary skill in the art.

Claims (22)

The invention claimed is:
1. A 3D bioprinter comprising:
(a) one or more printheads and one or more optical imaging apparatus disposed on one or more of the printheads in a manner such that the optical imaging apparatus is positioned to the side, above and/or below a nozzle and is capable of capturing images or video of bioink dispensed from the nozzle during printing;
(b) one or more control element;
(c) one or more processor and communication interface operably connecting and capable of communicating printability data from the one or more optical imaging apparatus to the one or more control element to control printing of a printed structure; and
(d) a non-transitory computer-readable storage media comprising:
(1) one or more process algorithms capable of quantifying printing characteristics chosen from one or more of shape, uniformity, thickness, size, and/or color of droplets or filaments of the bioink disposed from the nozzle from one or more images and/or video obtained with the optical imaging apparatus; and
(2) one or more learning algorithms capable of modifying and adjusting printing instructions and/or printing parameters based on one or more printability metrics to modify the printed structure in real time and before completion of the printing.
2. The 3D bioprinter of claim 1, wherein the one or more printability metrics are chosen from one or more of filament thickness, uniformity, roughness, continuity, color, opacity, and/or geometry at intersections and/or other directional changes.
3. The 3D bioprinter of claim 1, wherein the printing parameters are chosen from one or more of applied pressure, strain, force, or flow, printhead translation rate, bioink temperature, bioink composition, print surface temperature, layer height, infill pattern and density, nozzle diameter, nozzle shape, and/or nozzle material.
4. The 3D bioprinter of claim 1, wherein the one or more optical imaging apparatus is fixed or detachable.
5. The 3D bioprinter of claim 1, comprising one or more additional components chosen from motors, one or more print beds, one or more substrates for printing, one or more additional printed structures, one or more syringes, one or more platforms, one or more lasers, one or more operating controls, one or more power cables, and/or one or more USB cables.
6. The 3D bioprinter of claim 1, wherein the 3D bioprinter is in communication with or integrated with a database.
7. The 3D bioprinter of claim 1, wherein the 3D bioprinter is in communication with or integrated with a database for storing one or more printability analysis.
8. The 3D bioprinter of claim 1, wherein the 3D bioprinter is in communication with or integrated with a database for storing one or more printability analysis, which printability analysis is capable of being shared and compared across batches and users.
9. The 3D bioprinter of claim 1, wherein the one or more optical imaging apparatus comprises one or more infrared, near-infrared, visible, and/or UV sensors or cameras.
10. The 3D bioprinter of claim 1, wherein the printed structure is capable of serving as an optical or calibration target.
11. The 3D bioprinter of claim 1, wherein the printed structure is capable of serving as an optical or calibration target to allow rapid comparisons to known standard printable materials and internal controls.
12. The 3D bioprinter of claim 1, wherein the printed structure is capable of serving as an optical or calibration target and comprises one or more materials that are capable of being analyzed by software and thermal sensors or cameras including infrared-detecting sensors and/or cameras.
13. The 3D bioprinter of claim 1, wherein the printed structure which serves as an optical or calibration target comprises one or more of non-thermoresponsive filament, thermoresponsive filament, nozzle fidelic printable material, nozzle fidelic printable material chosen from thermoplastics or silicone, and/or materials that exhibit thermosensitivity.
14. The 3D bioprinter of claim 1, wherein the printing instructions comprise one or more of G-code files, STL files, text files, and/or manual inputs, wherein the manual inputs are capable of being provided by a user or generated through software.
15. The 3D bioprinter of claim 1, wherein the one or more optical imaging apparatus comprises one or more cameras and is disposed on one or more of the printheads that is an independent printhead not capable of depositing bioink.
16. The 3D bioprinter of claim 1, wherein the one or more optical imaging apparatus comprises one or more cameras and is disposed on one or more of the printheads that is capable of depositing material.
17. The 3D printer of bioprinter of claim 1, wherein the one or more optical imaging apparatus comprises at least two cameras disposed in a manner to capture one or more stereographic images.
18. The 3D bioprinter of claim 1, wherein the one or more optical imaging apparatus is capable of capturing images or videos in real-time during printing or post printing.
19. A 3D bioprinter comprising:
(a) one or more printheads and one or more optical imaging apparatus disposed on one or more of the printheads in a manner such that the optical imaging apparatus is positioned to the side, above, and/or below a nozzle and is capable of capturing images or video of bioink dispensed from the nozzle during printing;
(b) one or more control element;
(c) one or more processor and communication interface operably connecting and capable of communicating printability data from the one or more optical imaging apparatus to the one or more control element to control printing of a printed structure; and
(d) a non-transitory computer-readable storage media comprising:
(1) one or more process algorithms capable of quantifying printing characteristics chosen from one or more of shape, uniformity, thickness, size, and/or color of droplets or filaments of the bioink disposed from the nozzle from one or more images and/or video obtained with the optical imaging apparatus; and
(2) one or more learning algorithms capable of i) calibrating a bioink and ii) modifying and adjusting printing instructions and/or printing parameters based on one or more printability metrics to achieve a second printed structure.
20. The 3D bioprinter of claim 19, wherein the one or more learning algorithms capable of calibrating of the bioink are configured to compare imaging of the bioink against a calibration target.
21. The 3D bioprinter of claim 19, wherein one or more of the optical imaging apparatus, the one or more control element, the one or more process algorithms, and the one or more learning algorithms together are capable of calibrating the bioink by:
(a) depositing the one or more bioink under both variable and constant printing parameters;
(b) capturing an image of the deposited bioink;
(c) evaluating the image; and
(d) recommending one or more optimal printing parameter for the bioink.
22. The 3D bioprinter of claim 19, wherein the one or more learning algorithms are capable of recommending one or more optimal printing parameter for the bioink based on a captured image of deposited bioink.
US16/964,899 2018-01-26 2019-01-25 Systems and methods for optical assessments of bioink printability Active 2039-09-04 US11931966B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US16/964,899 US11931966B2 (en) 2018-01-26 2019-01-25 Systems and methods for optical assessments of bioink printability

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862622650P 2018-01-26 2018-01-26
US16/964,899 US11931966B2 (en) 2018-01-26 2019-01-25 Systems and methods for optical assessments of bioink printability
PCT/IB2019/000215 WO2019145795A2 (en) 2018-01-26 2019-01-25 Systems and methods for optical assessments of bioink printability

Publications (2)

Publication Number Publication Date
US20210031456A1 US20210031456A1 (en) 2021-02-04
US11931966B2 true US11931966B2 (en) 2024-03-19

Family

ID=66103024

Family Applications (1)

Application Number Title Priority Date Filing Date
US16/964,899 Active 2039-09-04 US11931966B2 (en) 2018-01-26 2019-01-25 Systems and methods for optical assessments of bioink printability

Country Status (2)

Country Link
US (1) US11931966B2 (en)
WO (1) WO2019145795A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3635105A4 (en) 2017-05-25 2021-03-31 Prellis Biologics, Inc. Three-dimensional printed organs, devices, and matrices
WO2019145795A2 (en) 2018-01-26 2019-08-01 Cellink Ab Systems and methods for optical assessments of bioink printability
CN112955306B (en) * 2018-07-31 2023-12-22 普瑞利思生物制品公司 Three-dimensional printing method and system
US11186736B2 (en) 2018-10-10 2021-11-30 Cellink Ab Double network bioinks
US11826951B2 (en) 2019-09-06 2023-11-28 Cellink Ab Temperature-controlled multi-material overprinting
US20220111579A1 (en) * 2020-10-14 2022-04-14 Applied Materials, Inc. Hybrid printing platform for 3d bioprinting of live organs
CN113977934A (en) * 2021-10-28 2022-01-28 上海大学 3D weaving path generation method for manufacturing molten filaments
SE2250597A1 (en) * 2022-05-19 2023-11-20 Cellink Bioprinting Ab Multi-sensor evaluation of a printing process

Citations (123)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236416A (en) 1991-05-23 1993-08-17 Ivac Corporation Syringe plunger position detection and alarm generation
US6103790A (en) 1994-03-01 2000-08-15 Elf Atochem S.A. Cellulose microfibril-reinforced polymers and their applications
JP2000513258A (en) 1996-06-28 2000-10-10 ジョンソン・アンド・ジョンソン・メディカル・リミテッド Use of oxidized cellulose and its complexes for chronic wound healing
US6509733B2 (en) 2000-12-20 2003-01-21 Caterpillar Inc Fluid cylinder with embedded positioning sensor
US20030059708A1 (en) 2000-06-09 2003-03-27 Tetsuya Yamamura Resin composition and three-dimensional object
WO2004092672A2 (en) 2003-04-10 2004-10-28 Praxair S. T. Technology, Inc. Amorphous carbon layer for heat exchangers
JP2005003610A (en) 2003-06-13 2005-01-06 Olympus Corp Dispenser, and automatic analyzer equipped with the same
US20050056713A1 (en) 2003-07-31 2005-03-17 Tisone Thomas C. Methods and systems for dispensing sub-microfluidic drops
US6942830B2 (en) 2000-04-17 2005-09-13 Envisiontec Gmbh Device and method for the production of three-dimensional objects
US7052263B2 (en) 2001-04-20 2006-05-30 Envisiontec Gmbh Apparatus for manufacturing a three-dimensional object
US7105357B1 (en) 1998-05-27 2006-09-12 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E. V. Method and device for processing extremely small substance quantities
US7122712B2 (en) 2002-12-02 2006-10-17 Lutri Thomas P Surgical bandage and methods for treating open wounds
US7195472B2 (en) 2001-04-23 2007-03-27 Envisiontec Gmbh Apparatus and method for the non-destructive separation of hardened material layers from a flat construction plane
WO2008055533A1 (en) 2006-11-10 2008-05-15 Envisiontec Gmbh Continuous, generative method and apparatus for the production of a three-dimensional object
WO2008122661A1 (en) 2007-04-10 2008-10-16 Bioregeneration Gmbh Process for the production of a structure comprising crystalline cellulose
US20080305012A1 (en) 2005-12-21 2008-12-11 Hans Camenisch Method and Device For Checking Whether a Liquid Transfer Has Been Successful
US20090003696A1 (en) 2007-06-29 2009-01-01 Canon Kabushiki Kaisha Image processing method and image processing apparatus
US20090022791A1 (en) 2005-04-22 2009-01-22 Kazuhiro Obae Porous cellulose aggregate and molding composition thereof
WO2009053100A1 (en) 2007-10-26 2009-04-30 Envisiontec Gmbh Process and freeform fabrication system for producing a three-dimensional object
US7636610B2 (en) 2006-07-19 2009-12-22 Envisiontec Gmbh Method and device for producing a three-dimensional object, and computer and data carrier useful therefor
EP2199380A2 (en) 2008-12-19 2010-06-23 Sanyo Electric Co., Ltd. Observation unit
US20100175759A1 (en) 2005-11-30 2010-07-15 Musashi Engineering, Inc. Method of adjusting nozzle clearance of liquid application apparatus, and liquid application apparatus
US20100200752A1 (en) 2009-02-06 2010-08-12 Siliconfile Technologies Inc. Image sensor capable of judging proximity to subject
US20100206224A1 (en) 2007-09-24 2010-08-19 Berner Fachhochschule fur Technik und informatik HTI Device for the deposition of layers
US7783371B2 (en) 2006-04-28 2010-08-24 Envisiontec Gmbh Device and method for producing a three-dimensional object by means of mask exposure
JP2010533855A (en) 2007-07-19 2010-10-28 ビオメリュー Apolipoprotein AII assay method for in vitro diagnosis of colorectal cancer
US20110024699A1 (en) 2009-07-28 2011-02-03 National Taiwan University Polymeric polymer containing poly(oxyethylene)-amine and application thereof to preparing silver nanoparticle
US7894921B2 (en) 2006-04-28 2011-02-22 Envisiontec Gmbh Device and method for producing a three-dimensional object by means of mask exposure
US7892474B2 (en) 2006-11-15 2011-02-22 Envisiontec Gmbh Continuous generative process for producing a three-dimensional object
EP1732746B1 (en) 2004-05-07 2011-04-27 Envisiontec GmbH Process for producing a threedimensional object with improved separation of hardened material layers from a base plane
US20110151482A1 (en) 2009-12-22 2011-06-23 Emery Michael P Automated developer for immuno-stained biological samples
WO2012051718A1 (en) 2010-10-22 2012-04-26 William Gelbart Automated slide scanning system for a microscope
WO2012056110A2 (en) 2010-10-27 2012-05-03 Upm-Kymmene Corporation Cell culture material based on microbial cellulose
WO2012071578A2 (en) 2010-11-24 2012-05-31 Bc Genesis Llc Pharmacology bioassays for drug discovery, toxicity evaluation and in vitro cancer research using a 3d nano-cellulose scaffold and living tissue
USRE43955E1 (en) 2004-05-10 2013-02-05 Envisiontec Gmbh Process for the production of a three-dimensional object with resolution improvement by pixel-shift
WO2012024675A9 (en) 2010-08-20 2013-02-07 Case Western Reserve University Continuous digital light processing additive manufacturing of implants
US8394313B2 (en) 2004-05-07 2013-03-12 Envisiontec Gmbh Process for the production of a three-dimensional object with an improved separation of hardened material layers from a construction plane
JP2013181167A (en) 2012-03-05 2013-09-12 Dai Ichi Kogyo Seiyaku Co Ltd Aqueous ink composition and writing instrument using the same
US20130309295A1 (en) 2011-02-04 2013-11-21 Paul Gatenholm Biosynthetic functional cellulose (bc) fibers as surgical sutures and reinforcement of implants and growing tissue
US20140074274A1 (en) 2012-09-07 2014-03-13 Makerbot Industries, Llc Three-dimensional printing of large objects
WO2014049204A1 (en) 2012-09-25 2014-04-03 Upm-Kymmene Corporation Three-dimensional cell culturing
US8691974B2 (en) 2009-09-28 2014-04-08 Virginia Tech Intellectual Properties, Inc. Three-dimensional bioprinting of biosynthetic cellulose (BC) implants and scaffolds for tissue engineering
CN103893825A (en) 2014-02-24 2014-07-02 钟春燕 Method for preparing bacterial cellulose compounded amnion extracellular matrix material containing collagen
EP2808671A1 (en) 2012-01-26 2014-12-03 Sharp Kabushiki Kaisha Fluorescence information reading device and fluorescence information reading method
US8931880B2 (en) 2010-10-21 2015-01-13 Organovo, Inc. Devices, systems, and methods for the fabrication of tissue
US20150013476A1 (en) 2012-02-13 2015-01-15 Thermo Fisher Scientific Oy Electronic Pipette
US20150045928A1 (en) 2013-08-07 2015-02-12 Massachusetts Institute Of Technology Automatic Process Control of Additive Manufacturing Device
US20150050719A1 (en) 2012-05-08 2015-02-19 Roche Diagnostic Operations, Inc. Dispensing assembly
KR101502236B1 (en) 2013-10-25 2015-03-12 한양대학교 산학협력단 3 dimensional chromatic confocal microscope, and method of generating information on depth of specimen using same
US20150105891A1 (en) 2013-10-11 2015-04-16 Advanced Solutions Life Sciences, Llc System and workstation for the design, fabrication and assembly of bio-material constructs
DE202015000178U1 (en) 2015-01-08 2015-04-16 Marius Becker Influence of the melting and softening zone by Peltier element in 3D printers after the melt layer process
US20150102351A1 (en) 2005-12-02 2015-04-16 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device, display device, and electronic device
WO2015066705A1 (en) 2013-11-04 2015-05-07 University Of Iowa Research Foundation Bioprinter and methods of using same
US9073261B2 (en) 2011-06-28 2015-07-07 Global Filtration Systems Apparatus and method for forming three-dimensional objects using linear solidification
WO2015101712A1 (en) 2013-12-30 2015-07-09 Upm-Kymmene Corporation Biomedical device
EP2916158A1 (en) 2014-03-06 2015-09-09 European Molecular Biology Laboratory Microscope
WO2015148646A2 (en) 2014-03-25 2015-10-01 Biobots, Inc. Methods, devices, and systems for the fabrication of materials and tissues utilizing electromagnetic radiation
US20150290874A1 (en) 2014-04-15 2015-10-15 Xyzprinting, Inc. Three dimensional printing apparatus
WO2015164844A1 (en) 2014-04-24 2015-10-29 Vutara, Inc. Super resolution microscopy
WO2015175457A1 (en) 2014-05-12 2015-11-19 Jonathan Allen Rowley Ready-to-print cells and integrated devices
US20150375453A1 (en) 2014-05-01 2015-12-31 Musc Foundation For Research Development Multidispensor cartesian robotic printer
US9315043B2 (en) 2013-07-31 2016-04-19 Organovo, Inc. Automated devices, systems, and methods for the fabrication of tissue
WO2016073782A1 (en) 2014-11-05 2016-05-12 Organovo, Inc. Engineered three-dimensional skin tissues, arrays thereof, and methods of making the same
WO2016091336A1 (en) 2014-12-12 2016-06-16 Ecole Polytechnique Federale De Lausanne (Epfl) A method for building a structure containing living cells
WO2016092106A1 (en) 2014-12-11 2016-06-16 ETH Zürich Graft scaffold for cartilage repair and process for making same
WO2016100856A1 (en) 2014-12-18 2016-06-23 Advanced Polymer Technology Ab Cellulose nanofibrillar bionik for 3d bioprinting for cell culturing, tissue engineering and regenerative medicine applications
US20160236414A1 (en) 2015-02-12 2016-08-18 Arevo Inc. Method to monitor additive manufacturing process for detection and in-situ correction of defects
US20160243618A1 (en) 2013-11-15 2016-08-25 Eos Gmbh Electro Optical Systems Device for Producing a Three-Dimensional Object in Layers
US20170031149A1 (en) 2010-11-30 2017-02-02 Robert Levin Compact, high-resolution fluorescence and brightfield microscope and methods of use
WO2017040675A1 (en) 2015-08-31 2017-03-09 Cellink Ab Clean chamber technology for 3d printers and bioprinters
US20170080641A1 (en) 2014-02-20 2017-03-23 Global Filtration Systems, A Dba Of Gulf Filtration Systems Inc. Apparatus and method for forming three-dimensional objects using a tilting solidification substrate
US20170100899A1 (en) 2011-01-31 2017-04-13 Global Filtration Systems, A Dba Of Gulf Filtration Systems Inc. Method and apparatus for making three-dimensional objects from multiple solidifiable materials
US9662821B2 (en) 2008-12-30 2017-05-30 Orthovita, Inc. Bioactive composites of polymer and glass and method for making same
WO2017109394A1 (en) 2015-12-23 2017-06-29 Compagnie Generale Des Etablissements Michelin Device for conveying additive manufacture container/plate assemblies
WO2017109395A1 (en) 2015-12-23 2017-06-29 Compagnie Generale Des Etablissements Michelin Additive manufacturing facility with successive nested confinement chambers
WO2017115056A1 (en) 2015-12-30 2017-07-06 Lab Skin Creations Method for manufacturing body substitutes by additive deposition
US20170210077A1 (en) 2014-08-12 2017-07-27 Carbon, Inc Three-Dimensional Printing Using Carriers with Release Mechanisms
US20170216498A1 (en) 2015-04-07 2017-08-03 Sichuan Revotek Co., Ltd. Compositions for cell-based three dimensional printing
US9725613B2 (en) 2013-05-24 2017-08-08 Fundació Eurecat Ink composition for inkjet printing
US20170225393A1 (en) 2016-02-04 2017-08-10 Global Filtration Systems, A Dba Of Gulf Filtration Systems Inc. Apparatus and method for forming three-dimensional objects using two-photon absorption linear solidification
WO2017152142A1 (en) 2016-03-03 2017-09-08 Desktop Metal, Inc. Additive manufacturing with metallic build materials
WO2017184839A1 (en) 2016-04-20 2017-10-26 The Brigham And Women's Hospital, Inc. Systems and methods for in vivo multi-material bioprinting
WO2017210663A1 (en) 2016-06-03 2017-12-07 Paul Gatenholm Preparation and applications of rgd conjugated polysaccharide bioinks with or without fibrin for 3d bioprinting of human skin with novel printing head for use as model for testing cosmetics and for transplantation
WO2017214592A1 (en) 2016-06-09 2017-12-14 Paul Gatenholm Preparation of modified cellulose nanofibrils with extracellular matrix components as 3d bioprinting bioinks
US20180071740A1 (en) 2015-05-29 2018-03-15 Roche Diagnostics Operations, Inc. Cartridge for dispensing particles and a reagent fluid
WO2018119989A1 (en) 2016-12-30 2018-07-05 苏州聚复高分子材料有限公司 Biological ink
CN108248020A (en) 2016-12-28 2018-07-06 西安科技大学 A kind of horizontal DLP shadow casting techniques face exposure molding machine and method
EP3366458A1 (en) 2016-11-15 2018-08-29 EOS GmbH Electro Optical Systems Transport unit and provision of a three-dimensional component
WO2018169965A1 (en) 2017-03-13 2018-09-20 The Texas A&M University System Nanocomposite ionic-covalent entanglement reinforcement mechanism and hydrogel
US20180273904A1 (en) 2015-10-02 2018-09-27 Wake Forest University Health Sciences Spontaneously beating cardiac organoid constructs and integrated body-on-chip apparatus containing the same
US20180281280A1 (en) 2017-04-04 2018-10-04 Allevi, Inc. Multi-headed auto-calibrating bioprinter with heads that heat, cool, and crosslink
WO2018187380A1 (en) 2017-04-03 2018-10-11 Greene Nguyen Deborah Lynn Use of engineered liver tissue constructs for modeling liver disorders
US20180297270A1 (en) 2015-12-16 2018-10-18 The Regents Of The University Of California Technique for three-dimensional nanoprinting
US20180326666A1 (en) 2017-05-12 2018-11-15 Brett Kelly System and method for computed axial lithography (cal) for 3d additive manufacturing
US20180341248A1 (en) * 2017-05-24 2018-11-29 Relativity Space, Inc. Real-time adaptive control of additive manufacturing processes using machine learning
US20180348247A1 (en) 2017-06-01 2018-12-06 Hitachi, Ltd. Dispensing apparatus
US20180345563A1 (en) 2017-06-02 2018-12-06 Cellink Ab 3D Printer and a Method for 3D Printing of a Construct
EP3415300A1 (en) 2017-06-16 2018-12-19 Cellink AB Printbeds, 3d-printers, methods and computer programs for regulation of a temperature of a printbed
WO2018234837A1 (en) 2017-06-23 2018-12-27 3Dhistech Kft. Device for moving a microscope stage and microscope comprising such a device
US20180370116A1 (en) 2017-06-27 2018-12-27 University Of Florida Research Foundation, Inc. Three-dimensional printing of reactive materials using intersecting jets
US20190016052A1 (en) 2017-07-11 2019-01-17 Daniel S. Clark 5d part growing machine with volumetric display technology
WO2019043529A1 (en) 2017-08-30 2019-03-07 Ecole Polytechnique Federale De Lausanne (Epfl) Methods and apparatus for three-dimensional fabrication by tomographic back projections
US10226894B2 (en) 2012-10-31 2019-03-12 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method and apparatus for making tangible products by layerwise manufacturing
US10272664B2 (en) 2015-01-14 2019-04-30 Xactiv, Inc. Fabrication of 3D objects via multiple build platforms
WO2019109127A1 (en) 2017-12-08 2019-06-13 Inventia Life Science Pty Ltd Bioprinter for fabricating 3d cell constructs
WO2019145795A2 (en) 2018-01-26 2019-08-01 Cellink Ab Systems and methods for optical assessments of bioink printability
US20190344500A1 (en) 2018-05-08 2019-11-14 9328-8082 Québec Inc. Modular additive manufacturing system and related methods for continuous part production
WO2019246623A9 (en) 2018-06-22 2020-02-06 Allevi, Inc. Systems and methods for improved dispensing, layering, and deposition of cross-linkable hydrogels
US20200070421A1 (en) 2018-09-05 2020-03-05 Carbon, Inc. Robotic additive manufacturing system
WO2020077118A1 (en) 2018-10-10 2020-04-16 Cellink Ab Double network bioinks
US20200122135A1 (en) 2014-10-22 2020-04-23 The Regents Of The University Of California High Definition Microdroplet Printer
WO2020086941A1 (en) 2018-10-25 2020-04-30 Cellink Ab Biogum and botanical gum hydrogel bioinks for the physiological 3d bioprinting of tissue constructs for in vitro culture and transplantation
US20200139623A1 (en) 2018-11-06 2020-05-07 3DTech Oy Modular systems and methods for performing additive manufacturing of objects
WO2020157077A2 (en) 2019-01-28 2020-08-06 Cellink Ab A compact fluorescence microscope and a cell monitoring system
WO2020165322A1 (en) 2019-02-15 2020-08-20 Cellink Ab Systems and methods for controlled dispensing of temperature-sensitive fluids in liquid handling and dispensing systems
WO2020176079A1 (en) 2019-02-26 2020-09-03 Cellink Ab Systems and methods for real-time optoelectronic assessments of fluid volume in fluid dispensing systems
CN111618302A (en) 2020-06-15 2020-09-04 佛山宇仁智能科技有限公司 Metal electric melting additive device and method for double-material printing cavity part
US20200353691A1 (en) * 2018-01-24 2020-11-12 Cellink Ab 3D Bioprinters with Cell Culture Monitoring Means
US20210069964A1 (en) 2019-09-06 2021-03-11 Cellink Ab Temperature-controlled multi-material overprinting
WO2021231717A1 (en) 2020-05-14 2021-11-18 Contraline, Inc. Biomaterial compositions and methods of delivery
WO2021243046A1 (en) 2020-05-28 2021-12-02 Contraline, Inc. Systems and methods for removing biomaterial implants
WO2022192768A1 (en) 2021-03-12 2022-09-15 Cellink Bioprinting Ab 3d bioprinter with continuous workflow capability
WO2023026099A1 (en) * 2021-08-27 2023-03-02 Aspect Biosystems Ltd. Microfluidic-based fiber formation methods and systems

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101288014B1 (en) 2009-06-12 2013-07-22 오티스 엘리베이터 컴파니 Drive assembly for a passenger conveyor

Patent Citations (157)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5236416A (en) 1991-05-23 1993-08-17 Ivac Corporation Syringe plunger position detection and alarm generation
US6103790A (en) 1994-03-01 2000-08-15 Elf Atochem S.A. Cellulose microfibril-reinforced polymers and their applications
JP2000513258A (en) 1996-06-28 2000-10-10 ジョンソン・アンド・ジョンソン・メディカル・リミテッド Use of oxidized cellulose and its complexes for chronic wound healing
US7105357B1 (en) 1998-05-27 2006-09-12 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E. V. Method and device for processing extremely small substance quantities
US6942830B2 (en) 2000-04-17 2005-09-13 Envisiontec Gmbh Device and method for the production of three-dimensional objects
US20030059708A1 (en) 2000-06-09 2003-03-27 Tetsuya Yamamura Resin composition and three-dimensional object
US6509733B2 (en) 2000-12-20 2003-01-21 Caterpillar Inc Fluid cylinder with embedded positioning sensor
US7052263B2 (en) 2001-04-20 2006-05-30 Envisiontec Gmbh Apparatus for manufacturing a three-dimensional object
US7195472B2 (en) 2001-04-23 2007-03-27 Envisiontec Gmbh Apparatus and method for the non-destructive separation of hardened material layers from a flat construction plane
US7122712B2 (en) 2002-12-02 2006-10-17 Lutri Thomas P Surgical bandage and methods for treating open wounds
WO2004092672A2 (en) 2003-04-10 2004-10-28 Praxair S. T. Technology, Inc. Amorphous carbon layer for heat exchangers
JP2005003610A (en) 2003-06-13 2005-01-06 Olympus Corp Dispenser, and automatic analyzer equipped with the same
US20050056713A1 (en) 2003-07-31 2005-03-17 Tisone Thomas C. Methods and systems for dispensing sub-microfluidic drops
US8394313B2 (en) 2004-05-07 2013-03-12 Envisiontec Gmbh Process for the production of a three-dimensional object with an improved separation of hardened material layers from a construction plane
EP1732746B1 (en) 2004-05-07 2011-04-27 Envisiontec GmbH Process for producing a threedimensional object with improved separation of hardened material layers from a base plane
USRE43955E1 (en) 2004-05-10 2013-02-05 Envisiontec Gmbh Process for the production of a three-dimensional object with resolution improvement by pixel-shift
US20090022791A1 (en) 2005-04-22 2009-01-22 Kazuhiro Obae Porous cellulose aggregate and molding composition thereof
US20100175759A1 (en) 2005-11-30 2010-07-15 Musashi Engineering, Inc. Method of adjusting nozzle clearance of liquid application apparatus, and liquid application apparatus
US20150102351A1 (en) 2005-12-02 2015-04-16 Semiconductor Energy Laboratory Co., Ltd. Semiconductor device, display device, and electronic device
US20080305012A1 (en) 2005-12-21 2008-12-11 Hans Camenisch Method and Device For Checking Whether a Liquid Transfer Has Been Successful
US7894921B2 (en) 2006-04-28 2011-02-22 Envisiontec Gmbh Device and method for producing a three-dimensional object by means of mask exposure
US7783371B2 (en) 2006-04-28 2010-08-24 Envisiontec Gmbh Device and method for producing a three-dimensional object by means of mask exposure
US7636610B2 (en) 2006-07-19 2009-12-22 Envisiontec Gmbh Method and device for producing a three-dimensional object, and computer and data carrier useful therefor
WO2008055533A1 (en) 2006-11-10 2008-05-15 Envisiontec Gmbh Continuous, generative method and apparatus for the production of a three-dimensional object
US7892474B2 (en) 2006-11-15 2011-02-22 Envisiontec Gmbh Continuous generative process for producing a three-dimensional object
WO2008122661A1 (en) 2007-04-10 2008-10-16 Bioregeneration Gmbh Process for the production of a structure comprising crystalline cellulose
US20090003696A1 (en) 2007-06-29 2009-01-01 Canon Kabushiki Kaisha Image processing method and image processing apparatus
JP2010533855A (en) 2007-07-19 2010-10-28 ビオメリュー Apolipoprotein AII assay method for in vitro diagnosis of colorectal cancer
US20100206224A1 (en) 2007-09-24 2010-08-19 Berner Fachhochschule fur Technik und informatik HTI Device for the deposition of layers
WO2009053100A1 (en) 2007-10-26 2009-04-30 Envisiontec Gmbh Process and freeform fabrication system for producing a three-dimensional object
EP2199380A2 (en) 2008-12-19 2010-06-23 Sanyo Electric Co., Ltd. Observation unit
US9662821B2 (en) 2008-12-30 2017-05-30 Orthovita, Inc. Bioactive composites of polymer and glass and method for making same
US20100200752A1 (en) 2009-02-06 2010-08-12 Siliconfile Technologies Inc. Image sensor capable of judging proximity to subject
US20110024699A1 (en) 2009-07-28 2011-02-03 National Taiwan University Polymeric polymer containing poly(oxyethylene)-amine and application thereof to preparing silver nanoparticle
US8691974B2 (en) 2009-09-28 2014-04-08 Virginia Tech Intellectual Properties, Inc. Three-dimensional bioprinting of biosynthetic cellulose (BC) implants and scaffolds for tissue engineering
US20110151482A1 (en) 2009-12-22 2011-06-23 Emery Michael P Automated developer for immuno-stained biological samples
WO2012024675A9 (en) 2010-08-20 2013-02-07 Case Western Reserve University Continuous digital light processing additive manufacturing of implants
US8931880B2 (en) 2010-10-21 2015-01-13 Organovo, Inc. Devices, systems, and methods for the fabrication of tissue
WO2012051718A1 (en) 2010-10-22 2012-04-26 William Gelbart Automated slide scanning system for a microscope
EP2975115A1 (en) 2010-10-27 2016-01-20 UPM-Kymmene Corporation Plant derived cell culture material
JP2013541956A (en) 2010-10-27 2013-11-21 ユー ピー エム キュンメネ コーポレーション Plant-derived cell culture material
FI123988B (en) 2010-10-27 2014-01-31 Upm Kymmene Corp Cell Culture Materials
WO2012056109A2 (en) 2010-10-27 2012-05-03 Upm-Kymmene Corporation Plant derived cell culture material
EP2633032B1 (en) 2010-10-27 2015-02-25 UPM-Kymmene Corporation Plant derived cell culture material
WO2012056111A2 (en) 2010-10-27 2012-05-03 Upm-Kymmene Corporation Drug delivery compositions
WO2012056110A2 (en) 2010-10-27 2012-05-03 Upm-Kymmene Corporation Cell culture material based on microbial cellulose
WO2012071578A2 (en) 2010-11-24 2012-05-31 Bc Genesis Llc Pharmacology bioassays for drug discovery, toxicity evaluation and in vitro cancer research using a 3d nano-cellulose scaffold and living tissue
US20170031149A1 (en) 2010-11-30 2017-02-02 Robert Levin Compact, high-resolution fluorescence and brightfield microscope and methods of use
US20170100899A1 (en) 2011-01-31 2017-04-13 Global Filtration Systems, A Dba Of Gulf Filtration Systems Inc. Method and apparatus for making three-dimensional objects from multiple solidifiable materials
US20130309295A1 (en) 2011-02-04 2013-11-21 Paul Gatenholm Biosynthetic functional cellulose (bc) fibers as surgical sutures and reinforcement of implants and growing tissue
US20150246482A1 (en) 2011-06-28 2015-09-03 Global Filtration Systems, A Dba Of Gulf Filtration Systems Inc. Apparatus and method for forming three-dimensional objects using linear solidification
US9073261B2 (en) 2011-06-28 2015-07-07 Global Filtration Systems Apparatus and method for forming three-dimensional objects using linear solidification
EP2808671A1 (en) 2012-01-26 2014-12-03 Sharp Kabushiki Kaisha Fluorescence information reading device and fluorescence information reading method
US20150013476A1 (en) 2012-02-13 2015-01-15 Thermo Fisher Scientific Oy Electronic Pipette
JP2013181167A (en) 2012-03-05 2013-09-12 Dai Ichi Kogyo Seiyaku Co Ltd Aqueous ink composition and writing instrument using the same
US20150050719A1 (en) 2012-05-08 2015-02-19 Roche Diagnostic Operations, Inc. Dispensing assembly
US20140074274A1 (en) 2012-09-07 2014-03-13 Makerbot Industries, Llc Three-dimensional printing of large objects
WO2014049204A1 (en) 2012-09-25 2014-04-03 Upm-Kymmene Corporation Three-dimensional cell culturing
US10226894B2 (en) 2012-10-31 2019-03-12 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method and apparatus for making tangible products by layerwise manufacturing
US9725613B2 (en) 2013-05-24 2017-08-08 Fundació Eurecat Ink composition for inkjet printing
US20170199507A1 (en) 2013-07-31 2017-07-13 Organovo, Inc. Automated devices, systems, and methods for the fabrication of tissue
US9315043B2 (en) 2013-07-31 2016-04-19 Organovo, Inc. Automated devices, systems, and methods for the fabrication of tissue
US20150045928A1 (en) 2013-08-07 2015-02-12 Massachusetts Institute Of Technology Automatic Process Control of Additive Manufacturing Device
US20150105891A1 (en) 2013-10-11 2015-04-16 Advanced Solutions Life Sciences, Llc System and workstation for the design, fabrication and assembly of bio-material constructs
KR101502236B1 (en) 2013-10-25 2015-03-12 한양대학교 산학협력단 3 dimensional chromatic confocal microscope, and method of generating information on depth of specimen using same
WO2015066705A1 (en) 2013-11-04 2015-05-07 University Of Iowa Research Foundation Bioprinter and methods of using same
US20160288414A1 (en) 2013-11-04 2016-10-06 University Of Iowa Research Foundation Bioprinter and methods of using same
US20160243618A1 (en) 2013-11-15 2016-08-25 Eos Gmbh Electro Optical Systems Device for Producing a Three-Dimensional Object in Layers
WO2015101712A1 (en) 2013-12-30 2015-07-09 Upm-Kymmene Corporation Biomedical device
US20170080641A1 (en) 2014-02-20 2017-03-23 Global Filtration Systems, A Dba Of Gulf Filtration Systems Inc. Apparatus and method for forming three-dimensional objects using a tilting solidification substrate
CN103893825A (en) 2014-02-24 2014-07-02 钟春燕 Method for preparing bacterial cellulose compounded amnion extracellular matrix material containing collagen
EP2916158A1 (en) 2014-03-06 2015-09-09 European Molecular Biology Laboratory Microscope
US20170172765A1 (en) 2014-03-25 2017-06-22 Biobots, Inc. Methods, devices, and systems for the fabrication of materials and tissues utilizing electromagnetic radiation
WO2015148646A2 (en) 2014-03-25 2015-10-01 Biobots, Inc. Methods, devices, and systems for the fabrication of materials and tissues utilizing electromagnetic radiation
US20150290874A1 (en) 2014-04-15 2015-10-15 Xyzprinting, Inc. Three dimensional printing apparatus
WO2015164844A1 (en) 2014-04-24 2015-10-29 Vutara, Inc. Super resolution microscopy
US20150375453A1 (en) 2014-05-01 2015-12-31 Musc Foundation For Research Development Multidispensor cartesian robotic printer
US20170079262A1 (en) 2014-05-12 2017-03-23 Roosterbio, Inc. Ready-to-print cells and integrated devices
WO2015175457A1 (en) 2014-05-12 2015-11-19 Jonathan Allen Rowley Ready-to-print cells and integrated devices
US20170210077A1 (en) 2014-08-12 2017-07-27 Carbon, Inc Three-Dimensional Printing Using Carriers with Release Mechanisms
US20200122135A1 (en) 2014-10-22 2020-04-23 The Regents Of The University Of California High Definition Microdroplet Printer
WO2016073782A1 (en) 2014-11-05 2016-05-12 Organovo, Inc. Engineered three-dimensional skin tissues, arrays thereof, and methods of making the same
JP2018501845A (en) 2014-12-11 2018-01-25 イーティーエッチ チューリッヒ Graft scaffold for cartilage repair and manufacturing method thereof
WO2016092106A1 (en) 2014-12-11 2016-06-16 ETH Zürich Graft scaffold for cartilage repair and process for making same
US20170348458A1 (en) 2014-12-11 2017-12-07 Eth Zurich Graft scaffold for cartilage repair and process for making same
WO2016091336A1 (en) 2014-12-12 2016-06-16 Ecole Polytechnique Federale De Lausanne (Epfl) A method for building a structure containing living cells
US10675379B2 (en) 2014-12-18 2020-06-09 Cellink Ab Cellulose nanofibrillar bioink for 3D bioprinting for cell culturing, tissue engineering and regenerative medicine applications
US20230398259A1 (en) 2014-12-18 2023-12-14 Cellink Ab Cellulose nanofibrillar bioink for 3d bioprinting for cell culturing, tissue engineering and regenerative medicine applications
US20200164103A1 (en) 2014-12-18 2020-05-28 Cellink Ab Cellulose nanofibrillar bioink for 3d bioprinting for cell culturing, tissue engineering and regenerative medicine applications
US20200206385A1 (en) 2014-12-18 2020-07-02 Cellink Ab Cellulose nanofibrillar bioink for 3d bioprinting for cell culturing, tissue engineering and regenerative medicine applications
US20170368225A1 (en) 2014-12-18 2017-12-28 Cellink Ab Cellulose nanofibrillar bioink for 3d bioprinting for cell culturing, tissue engineering and regenerative medicine applications
WO2016100856A1 (en) 2014-12-18 2016-06-23 Advanced Polymer Technology Ab Cellulose nanofibrillar bionik for 3d bioprinting for cell culturing, tissue engineering and regenerative medicine applications
DE202015000178U1 (en) 2015-01-08 2015-04-16 Marius Becker Influence of the melting and softening zone by Peltier element in 3D printers after the melt layer process
US10272664B2 (en) 2015-01-14 2019-04-30 Xactiv, Inc. Fabrication of 3D objects via multiple build platforms
US20160236414A1 (en) 2015-02-12 2016-08-18 Arevo Inc. Method to monitor additive manufacturing process for detection and in-situ correction of defects
US20170216498A1 (en) 2015-04-07 2017-08-03 Sichuan Revotek Co., Ltd. Compositions for cell-based three dimensional printing
US20180071740A1 (en) 2015-05-29 2018-03-15 Roche Diagnostics Operations, Inc. Cartridge for dispensing particles and a reagent fluid
WO2017040675A1 (en) 2015-08-31 2017-03-09 Cellink Ab Clean chamber technology for 3d printers and bioprinters
US20180326665A1 (en) 2015-08-31 2018-11-15 Cellink Ab Clean Chamber Technology for 3D Printers and Bioprinters
US20180273904A1 (en) 2015-10-02 2018-09-27 Wake Forest University Health Sciences Spontaneously beating cardiac organoid constructs and integrated body-on-chip apparatus containing the same
US20180297270A1 (en) 2015-12-16 2018-10-18 The Regents Of The University Of California Technique for three-dimensional nanoprinting
WO2017109395A1 (en) 2015-12-23 2017-06-29 Compagnie Generale Des Etablissements Michelin Additive manufacturing facility with successive nested confinement chambers
WO2017109394A1 (en) 2015-12-23 2017-06-29 Compagnie Generale Des Etablissements Michelin Device for conveying additive manufacture container/plate assemblies
WO2017115056A1 (en) 2015-12-30 2017-07-06 Lab Skin Creations Method for manufacturing body substitutes by additive deposition
US20170225393A1 (en) 2016-02-04 2017-08-10 Global Filtration Systems, A Dba Of Gulf Filtration Systems Inc. Apparatus and method for forming three-dimensional objects using two-photon absorption linear solidification
WO2017152142A1 (en) 2016-03-03 2017-09-08 Desktop Metal, Inc. Additive manufacturing with metallic build materials
WO2017184839A1 (en) 2016-04-20 2017-10-26 The Brigham And Women's Hospital, Inc. Systems and methods for in vivo multi-material bioprinting
WO2017210663A1 (en) 2016-06-03 2017-12-07 Paul Gatenholm Preparation and applications of rgd conjugated polysaccharide bioinks with or without fibrin for 3d bioprinting of human skin with novel printing head for use as model for testing cosmetics and for transplantation
US20190160203A1 (en) 2016-06-03 2019-05-30 Cellink Ab Preparation and applications of rgd conjugated polysaccharide bioinks with or without fibrin for 3d bioprinting of human skin with novel printing head for use as model for testing cosmetics and for transplantation
EP3463822A1 (en) 2016-06-03 2019-04-10 Cellink AB Preparation and applications of rgd conjugated polysaccharide bioinks with or without fibrin for 3d bioprinting of human skin with novel printing head for use as model for testing cosmetics and for transplantation
WO2017214592A1 (en) 2016-06-09 2017-12-14 Paul Gatenholm Preparation of modified cellulose nanofibrils with extracellular matrix components as 3d bioprinting bioinks
JP7053503B2 (en) 2016-06-09 2022-04-12 セリンク エービー Preparation of Cellulose Nanofibrils Modified with Extracellular Matrix Components as 3D Bioprinting Bioinks
EP3469004A1 (en) 2016-06-09 2019-04-17 Cellink AB Preparation of modified cellulose nanofibrils with extracellular matrix components as 3d bioprinting bioinks
US20190209738A1 (en) 2016-06-09 2019-07-11 Paul Gatenholm Preparation and applications of modified cellulose nanofibrils with extracellular matrix components as 3d bioprinting bioinks to control cellular fate processes such as adhesion, proliferation and differentiation
EP3366458A1 (en) 2016-11-15 2018-08-29 EOS GmbH Electro Optical Systems Transport unit and provision of a three-dimensional component
CN108248020A (en) 2016-12-28 2018-07-06 西安科技大学 A kind of horizontal DLP shadow casting techniques face exposure molding machine and method
WO2018119989A1 (en) 2016-12-30 2018-07-05 苏州聚复高分子材料有限公司 Biological ink
US20200071550A1 (en) 2017-03-13 2020-03-05 The Texas A&M University System Nanocomposite Ionic-Covalent Entanglement Reinforcement Mechanism and Hydrogel
WO2018169965A1 (en) 2017-03-13 2018-09-20 The Texas A&M University System Nanocomposite ionic-covalent entanglement reinforcement mechanism and hydrogel
WO2018187380A1 (en) 2017-04-03 2018-10-11 Greene Nguyen Deborah Lynn Use of engineered liver tissue constructs for modeling liver disorders
US20180281280A1 (en) 2017-04-04 2018-10-04 Allevi, Inc. Multi-headed auto-calibrating bioprinter with heads that heat, cool, and crosslink
US20180326666A1 (en) 2017-05-12 2018-11-15 Brett Kelly System and method for computed axial lithography (cal) for 3d additive manufacturing
US20180341248A1 (en) * 2017-05-24 2018-11-29 Relativity Space, Inc. Real-time adaptive control of additive manufacturing processes using machine learning
US20180348247A1 (en) 2017-06-01 2018-12-06 Hitachi, Ltd. Dispensing apparatus
US20180345563A1 (en) 2017-06-02 2018-12-06 Cellink Ab 3D Printer and a Method for 3D Printing of a Construct
EP3415300A1 (en) 2017-06-16 2018-12-19 Cellink AB Printbeds, 3d-printers, methods and computer programs for regulation of a temperature of a printbed
WO2018234837A1 (en) 2017-06-23 2018-12-27 3Dhistech Kft. Device for moving a microscope stage and microscope comprising such a device
US20180370116A1 (en) 2017-06-27 2018-12-27 University Of Florida Research Foundation, Inc. Three-dimensional printing of reactive materials using intersecting jets
US20190016052A1 (en) 2017-07-11 2019-01-17 Daniel S. Clark 5d part growing machine with volumetric display technology
WO2019043529A1 (en) 2017-08-30 2019-03-07 Ecole Polytechnique Federale De Lausanne (Epfl) Methods and apparatus for three-dimensional fabrication by tomographic back projections
WO2019109127A1 (en) 2017-12-08 2019-06-13 Inventia Life Science Pty Ltd Bioprinter for fabricating 3d cell constructs
US20200353691A1 (en) * 2018-01-24 2020-11-12 Cellink Ab 3D Bioprinters with Cell Culture Monitoring Means
WO2019145795A2 (en) 2018-01-26 2019-08-01 Cellink Ab Systems and methods for optical assessments of bioink printability
US20190344500A1 (en) 2018-05-08 2019-11-14 9328-8082 Québec Inc. Modular additive manufacturing system and related methods for continuous part production
WO2019246623A9 (en) 2018-06-22 2020-02-06 Allevi, Inc. Systems and methods for improved dispensing, layering, and deposition of cross-linkable hydrogels
US20200070421A1 (en) 2018-09-05 2020-03-05 Carbon, Inc. Robotic additive manufacturing system
US11186736B2 (en) 2018-10-10 2021-11-30 Cellink Ab Double network bioinks
WO2020077118A1 (en) 2018-10-10 2020-04-16 Cellink Ab Double network bioinks
US20210179871A1 (en) 2018-10-10 2021-06-17 Cellink Ab Double network bioinks
US20210001009A1 (en) 2018-10-25 2021-01-07 Cellink Ab Biogum and botanical gum hydrogel bioinks for the physiological 3d bioprinting of tissue constructs for in vitro culture and transplantation
WO2020086941A1 (en) 2018-10-25 2020-04-30 Cellink Ab Biogum and botanical gum hydrogel bioinks for the physiological 3d bioprinting of tissue constructs for in vitro culture and transplantation
EP3799571A1 (en) 2018-10-25 2021-04-07 Cellink AB Biogum and botanical gum hydrogel bioinks for the physiological 3d bioprinting of tissue constructs for in vitro culture and transplantation
US20200139623A1 (en) 2018-11-06 2020-05-07 3DTech Oy Modular systems and methods for performing additive manufacturing of objects
WO2020094913A1 (en) 2018-11-06 2020-05-14 3DTech Oy Modular systems and methods for performing additive manufacturing of objects
WO2020157077A2 (en) 2019-01-28 2020-08-06 Cellink Ab A compact fluorescence microscope and a cell monitoring system
WO2020165322A1 (en) 2019-02-15 2020-08-20 Cellink Ab Systems and methods for controlled dispensing of temperature-sensitive fluids in liquid handling and dispensing systems
US20220161499A1 (en) 2019-02-26 2022-05-26 Cellink Ab Systems and methods for real-time optoelectronic assessments of fluid volume in fluid dispensing systems
EP3931532A1 (en) 2019-02-26 2022-01-05 Cellink AB Systems and methods for real-time optoelectronic assessments of fluid volume in fluid dispensing systems
WO2020176079A1 (en) 2019-02-26 2020-09-03 Cellink Ab Systems and methods for real-time optoelectronic assessments of fluid volume in fluid dispensing systems
US20220105676A1 (en) 2019-09-06 2022-04-07 Cellink Ab Temperature-controlled multi-material overprinting
US20210069964A1 (en) 2019-09-06 2021-03-11 Cellink Ab Temperature-controlled multi-material overprinting
US11826951B2 (en) 2019-09-06 2023-11-28 Cellink Ab Temperature-controlled multi-material overprinting
WO2021231717A1 (en) 2020-05-14 2021-11-18 Contraline, Inc. Biomaterial compositions and methods of delivery
WO2021243046A1 (en) 2020-05-28 2021-12-02 Contraline, Inc. Systems and methods for removing biomaterial implants
CN111618302A (en) 2020-06-15 2020-09-04 佛山宇仁智能科技有限公司 Metal electric melting additive device and method for double-material printing cavity part
WO2022192768A1 (en) 2021-03-12 2022-09-15 Cellink Bioprinting Ab 3d bioprinter with continuous workflow capability
WO2023026099A1 (en) * 2021-08-27 2023-03-02 Aspect Biosystems Ltd. Microfluidic-based fiber formation methods and systems

Non-Patent Citations (183)

* Cited by examiner, † Cited by third party
Title
(Abushall, Hany et al.) Co-Pending Application No. PCT/US19/19664, filed Feb. 26, 2019, Specification, Claims, Figures.
(Abushall, Hany et al.) Co-Pending European Application No. 19917298.2, filed Aug. 5, 2021, Specification, Claims, Figures (See WO 2020/176079).
(Abushall, Hany et al.) Co-Pending U.S. Appl. No. 17/434,321, filed Aug. 26, 2021, Specification, Claims, and Figures.
(Boyer, Christen et al.) Co-pending U.S. Appl. No. 17/011,767, filed Sep. 3, 2020, Specification, Claims, Figures.
(Boyer, Christen et al.) Co-pending U.S. Appl. No. 17/554,789, filed Dec. 17, 2021, Specification, Claims, Figures.
(Gatenholm, Erik et al.) Co-pending International Application No. PCT/EP2020/052062, filed Jan. 28, 2020, Specification, Claims, Figures, 49 pages (See WO2020157077).
(Gatenholm, Paul) Co-pending European Application No. 17807642.8 filed Jan. 3, 2019, Specification, Claims, Figures.
(Gatenholm, Paul) Co-pending European Patent Application No. 15871191.1 filed Jul. 18, 2017, Specification, Claims, Figures (See WO2016100856).
(Gatenholm, Paul) Co-pending European Patent Application No. 17811137.3, filed Jan. 2, 2019, Claims (Attached), Specification, and Figures (See PCT/US17/036895).
(Gatenholm, Paul) Co-pending International Patent Application No. PCT/US15/66755 filed Dec. 18, 2015, published as WO 2016/100856 on Jun. 23, 2016, Specification, Claims, Figures.
(Gatenholm, Paul) Co-pending International Patent Application No. PCT/US17/035861 filed Jun. 3, 2017, published as WO 2017/210663 on Dec. 7, 2017, Specification, Claims, Figures.
(Gatenholm, Paul) Co-pending International Patent Application No. PCT/US17/036895, filed Jun. 9, 2017, which published as WO 2017/214592 on Dec. 14, 2017, Specification, Claims, Figures.
(Gatenholm, Paul) Co-pending Japanese Application No. 2018-564332, filed on Dec. 7, 2018, Specification, Claims, and Figures (see PCT/US17/36895).
(Gatenholm, Paul) Co-pending Japanese Application No. 2019-516082 filed Nov. 30, 2018, Specification, Claims, Figures (see PCT/US17/35861).
(Gatenholm, Paul) Co-pending U.S. Appl. No. 15/537,154, filed Jun. 16, 2017, Specification, Claims, Figures.
(Gatenholm, Paul) Co-pending U.S. Appl. No. 16/306,436, filed Nov. 30, 2018, Specification, Claims, Figures.
(Gatenholm, Paul) Co-pending U.S. Appl. No. 16/307,852, filed Dec. 6, 2018, Specification, Claims, Figures.
(Gatenholm, Paul) Co-pending U.S. Appl. No. 16/777,146, filed Jan. 30, 2020, Specification, Claims, Figures.
(Gatenholm, Paul) Co-pending U.S. Appl. No. 16/799,062, filed Feb. 24, 2020, Specification, Claims, Figures.
(Martinez, Hector et al.) Co-Pending Application No. PCT/US22/20148, filed Mar. 14, 2022, Specification, Claims, Figures.
(Martinez, Hector et al.) Co-pending International Application No. PCT/EP2020/053721, filed Feb. 13, 2020, Specification, Claims, Figures, 46 pages (See WO2020/165322).
(Martinez, Hector et al.) Co-pending International Application No. PCT/US19/55684, filed Oct. 10, 2019, Specification, Claims, Figures.
(Martinez, Hector et al.) Co-Pending U.S. Appl. No. 17/048,755, filed Oct. 15, 2020, Specification, Claims, Figures.
(Redwan, Adel Itadele Namro et al.) Co-pending International Application No. PCT/US19/58025, filed Oct. 25, 2019, Specification, Claims, Figures.
(Redwan, Adel Itedale Namro et al.) Co-pending European Patent Application No. 19874873.3 filed Dec. 29, 2020, Specification and Figures (See PCT/US2019/058025) and amended claims (3 pages).
(Redwan, Adel Itedale Namro et al.) Co-pending Japanese Application No. 2020-549630, filed Sep. 15, 2020, Specification, Claims, Figures (see PCT/US19/58025).
(Redwan, Adel Itedale Namro et al.) Co-pending Japanese Application No. 2022-035620, filed Mar. 8, 2022, Specification, Claims, Figures (see PCT/US19/58025).
(Redwan, Adel Itedale Namro et al.) Co-pending Korean Application No. 10-2020-7031999 filed Nov. 5, 2020, Specification, Claims, and Figures (See PCT/2019/058025).
(Redwan, Adel Itedale Namro et al.) Co-pending Korean Application No. 10-2022-7017436 filed May 24, 2022, Specification, Claims, and Figures (See PCT/2019/058025 for English Translation).
(Redwan, Adel Itedale Namro et al.) Co-Pending U.S. Appl. No. 16/979,452, filed Sep. 9, 2020, Specification, Claims, Figures.
(Thayer, Patrick et al.) Co-pending Application No. PCT/IB2019/000215, filed Jan. 25, 2019, Specification, Claims, and Figures.
Ahadian et al. "Bioconjugated Hydrogels for Tissue Engineering and Regenerative Medicine," Bioconjuoate Chem. Jul. 15, 2015 (Jul. 15, 2015) vol. 26, Iss. 10, pp. 1984-2001.
Andrade et al. "Improving the Affinity of Fibroblasts for Bacterial Cellulose Using .—Carbohydrate-Binding Modules Fused to RGD," Journal of Biomedical Materials Research. Jan. 22, 2009 (Jan. 22, 2009) vol. 92, Iss. 1, pp. 9-17.
Apelgren, P. et al., PLoS ONE, "Chondrocytes and stem cells in 3D-bioprinted structures create human cartilage in vivo", published Dec. 13, 2017, vol. 12, No. 12, 16 pages.
Bäckdahl, H., Esguerra, M., Delbro, D., Risberg, B., and Gatenholm, P., Engineering microporosity in bacterial cellulose scaffolds, Journal of Tissue Engineering and Regenerative Medicine, 2 (6), 320-330 (2008).
Bodin, A. et al., "Modification of Nanocellulose with a Xyloglucan-RGD Conjugate Enhances Adhesion and Proliferation of Endothelial Cells: Implications for Tissue Engineering", Biomacromolecules 2007, 8, 3697-3704, 8 pages.
Bovine Collagen Solution, Sigma Aldrich, 2020, https://www.sigmaaldrich.com/catalog/product/aldrich/804614?lang=en&region=US. (International Search Report of PCT/US2019/055684 dated Jan. 28, 2020 indicates this reference was retrieved as early as Jan. 6, 2020. This copy retrieved Apr. 14, 2020.).
Chang, R. et al., "Direct Cell Writing of 3D Microorgan for In Vitro Pharmacokinetic Model", Tissue Engineering: Part C, vol. 14, No. 2, 2008, 11 pages.
Co-pending Application No. PCT/IB2019/000215, International Preliminary Report on Patentability, 14 pages.
Co-pending Application No. PCT/IB2019/000215, International Search Report and Written Opinion dated Feb. 9, 2019 and Written Opinion dated Jul. 4, 2019, 20 pages.
Co-Pending Application No. PCT/US19/19664, International Search Report and Written Opinion dated Jun. 6, 2019, 11 pages.
Co-Pending Application No. PCT/US22/20148, International Search Report and Written Opinion dated Jun. 29, 2022, 13 pages.
Co-pending European Application No. 17807642.8, Response to Jul. 3, 2020 Communication pursuant to Rules 70(2) and 70a(2) EPC filed Jan. 13, 2021, 12 pages.
Co-Pending European Application No. 19917298.2, Amended Claims filed Mar. 25, 2022, 13 pages.
Co-Pending European Application No. 19917298.2, Extended European Search Report dated Sep. 8, 2022, 9 pages.
Co-pending European Patent Application No. 15871191.1, File History, Nov. 2019 to Feb. 2020, 30 pages.
Co-pending European Patent Application No. 15871191.1, File History, Oct. 2018 to Jul. 2019, 28 pages.
Co-pending European Patent Application No. 15871191.1, Letter and Communication pursuant to Rule 114(2) EPC, dated Jun. 12, 2018, 7 pages.
Co-pending European Patent Application No. 15871191.1, Supplemental Search and Opinion, dated Sep. 18, 2018, 8 pages.
Co-pending European Patent Application No. 17807642.8 Communication Pursuant to Rule 164(1) dated Jan. 27, 2020, 19 pages.
Co-pending European Patent Application No. 17807642.8 Communication Pursuant to Rules 161(2) and 162 EPC dated Feb. 1, 2019, 4 pages.
Co-pending European Patent Application No. 17807642.8 Response to Jan. 27, 2020 Communication Pursuant to Rule 164(1) filed Apr. 8, 2020, 3 pages.
Co-pending European Patent Application No. 17807642.8, Extended European Search Report dated Jun. 16, 2020, 21 pages.
Co-pending European Patent Application No. 17811137.3, Communication under Article 94(3) EPC dated Dec. 10, 2020, 6 pages.
Co-pending European Patent Application No. 17811137.3, Extended European Search Report dated Apr. 2, 2020, 9 pages.
Co-pending European Patent Application No. 17811137.3, Response to Apr. 1, 2020 Communication pursuant to Rules 70(2) and 70a(2) EPC filed Oct. 30, 2020, 11 pages.
Co-pending European Patent Application No. 17811137.3, Response to Dec. 10, 2020 Communication under Article 94(3) EPC, filed Jun. 21, 2021, 15 pages.
Co-pending European Patent Application No. 19874873.3, Communication pursuant to Article 94(3) EPC, dated Dec. 8, 2022, 6 pages.
Co-pending European Patent Application No. 19874873.3, Extended European Search Report, dated Feb. 8, 2022, 10 pages.
Co-pending European Patent Application No. 19874873.3, Response to the Feb. 25, 2022 Communication Pursuant to Rules 70(2) and 70a(2) EPC, dated Sep. 7, 2022, 11 pages.
Co-pending International Application No. PCT/EP2020/052062, International Search Report and Written Opinion, dated Aug. 24, 2020, 19 pages.
Co-pending International Application No. PCT/EP2020/053721, International Search Report and Written Opinion, dated May 18, 2020, 11 pages.
Co-pending International Application No. PCT/US19/55684, International Search Report and Written Opinion dated Jan. 28, 2020, 8 pages.
Co-pending International Application No. PCT/US19/58025, International Search Report and Written Opinion dated Feb. 6, 2020, 10 pages.
Co-pending International Patent Application No. PCT/US15/66755, International Preliminary Report on Patentability dated Jun. 20, 2017, 6 pages.
Co-pending International Patent Application No. PCT/US15/66755, International Search Report and Written Opinion dated Apr. 28, 2016, 8 pages.
Co-pending International Patent Application No. PCT/US17/035861 filed Jun. 3, 2017, International Preliminary Report on Patentability dated Dec. 4, 2018, 11 pages.
Co-pending International Patent Application No. PCT/US17/035861 International Search Report and Written Opinion dated Aug. 17, 2017, 14 pages.
Co-pending International Patent Application No. PCT/US17/036895, International Preliminary Report on Patentability dated Aug. 17, 2017, 7 pages.
Co-pending International Patent Application No. PCT/US17/036895, International Search Report and Written Opinion dated Sep. 6, 2017, 9 pages.
Co-pending International Patent Application No. PCT/US2017/035861 filed Jun. 3, 2017, International Search Report and Written Opinion dated Aug. 17, 2017.
Co-pending Japanese Application No. 2018-564332 Certificate of Patent 7053503, date of registration Apr. 4, 2022, 2 pages.
Co-pending Japanese Application No. 2018-564332, Office Action dated May 14, 2021, 9 pages and English Translation, 10 pages.
Co-pending Japanese Application No. 2018-564332, Response to May 14, 2021 Office Action filed Oct. 13, 2021, 6 pages and English Translation of Amended Claims, 5 pages.
Co-pending Japanese Application No. 2019-516082, Decision to Grant dated Oct. 26, 2022, 4 pages.
Co-pending Japanese Application No. 2019-516082, Final Office Action dated Dec. 16, 2021 (3 pages) and English Translation (4 pages).
Co-pending Japanese Application No. 2019-516082, First Office Action dated Mar. 1, 2021 (3 pages) and English Translation (4 pages).
Co-pending Japanese Application No. 2019-516082, Response to Dec. 16, 2021 Final Office Action, dated Jun. 17, 2022 (9 pages) and English Translation (9 pages).
Co-pending Japanese Application No. 2019-516082, Response to First Office Action filed Aug. 2, 2021 (9 pages) and English Version (8 pages).
Co-pending Japanese Application No. 2020-549630, Decision of Rejection dated Dec. 12, 2022 (1 page) and English Translation (2 pages).
Co-pending Japanese Application No. 2020-549630, English Version of Claims filed Nov. 27, 2020, 3 pages.
Co-pending Japanese Application No. 2020-549630, Office Action dated Apr. 18, 2022 (4 pages) and English Translation (5 pages).
Co-pending Japanese Application No. 2020-549630, Office Action dated Aug. 18, 2022 (3 pages) and English Translation (4 pages).
Co-pending Japanese Application No. 2020-549630, Office Action dated Dec. 9, 2021 (4 pages) and English Translation (4 pages).
Co-pending Japanese Application No. 2020-549630, Office Action dated Jun. 21, 2021 (6 pages) and English Translation (7 pages).
Co-pending Japanese Application No. 2020-549630, Response to Apr. 18, 2022 Office Action, dated Jul. 15, 2022 (6 pages) and English Version (6 pages).
Co-pending Japanese Application No. 2020-549630, Response to Aug. 18, 2022 Office Action dated Nov. 4, 2022 (7 pages) and English Translation of the claims (3 pages).
Co-pending Japanese Application No. 2020-549630, Response to Dec. 9, 2021 Office Action, filed Mar. 9, 2022 (6 pages) and English Translation of the Amended Claims (4 pages).
Co-pending Japanese Application No. 2020-549630, Response to Jun. 21, 2021 Office Action, filed Nov. 19, 2021 (9 pages) and English Translation of the Amended Claims (4 pages).
Co-pending Japanese Application No. 2022-035620, Office Action dated Oct. 24, 2023 (7 pages) and English Translation of the Claims (8 pages).
Co-pending Japanese Application No. 2022-035620, Voluntary Amendment dated Oct. 24, 2022 (5 pages) and English Translation of the Claims (10 pages).
Co-pending Korean Application No. 10-2020-7031999 Office Action dated Aug. 25, 2021 (10 pages) with English translation (9 pages).
Co-pending Korean Application No. 10-2020-7031999 Office Action dated Feb. 23, 2022 (4 pages) with English translation (3 pages).
Co-pending Korean Application No. 10-2020-7031999 Response to Aug. 25, 2021 Office Action, filed Nov. 25, 2021 (25 pages) with English translation of the amended claims (5 pages).
Co-pending Korean Application No. 10-2020-7031999 Voluntary Amendment filed Apr. 2, 2021 (15 pages) with English version of the amended claims (5 pages).
Co-pending Korean Application No. 10-2022-7017436, Office Action dated Oct. 23, 2023 (9 pages) and English translation (9 pages).
Co-pending Korean Application No. 10-2022-7017436, Remarks and Claims as filed (11 pages) May 24, 2022, with English version (9 pages).
Co-pending U.S. Appl. No. 15/537,154 Non-Final Office Action dated Feb. 27, 2019, 6 pages.
Co-pending U.S. Appl. No. 15/537,154 Notice of Allowance dated Apr. 28, 2020, 6 pages.
Co-pending U.S. Appl. No. 15/537,154 Official Interview Summary dated Mar. 13, 2019, 3 pages.
Co-pending U.S. Appl. No. 15/537,154 Preliminary Amendment filed Jun. 16, 2017, 7 pages.
Co-pending U.S. Appl. No. 15/537,154 Response to Feb. 27, 2019 Non-Final Office Action, filed Mar. 18, 2019, 6 pages.
Co-pending U.S. Appl. No. 15/537,154 Response to Oct. 18, 2018 Restriction Requirement, dated Dec. 18, 2018, 7 pages.
Co-pending U.S. Appl. No. 15/537,154 Restriction Requirement dated Oct. 18, 2018, 8 pages.
Co-pending U.S. Appl. No. 15/537,154 Supplemental Notice of Allowance dated May 5, 2020, 3 pages.
Co-pending U.S. Appl. No. 16/306,436, Final Office Action dated May 17, 2022, 17 pages.
Co-pending U.S. Appl. No. 16/306,436, Non-Final Office Action dated Nov. 18, 2021, 13 pages.
Co-pending U.S. Appl. No. 16/306,436, Preliminary Amendment filed Nov. 30, 2018, 5 pages.
Co-pending U.S. Appl. No. 16/306,436, Response to Jun. 28, 2021 Restriction Requirement, filed Aug. 27, 2021, 5 pages.
Co-pending U.S. Appl. No. 16/306,436, Response to Nov. 18, 2021 Non-Final Office Action, dated Feb. 17, 2022, 7 pages.
Co-pending U.S. Appl. No. 16/306,436, Restriction Requirement dated Jun. 28, 2021, 11 pages.
Co-pending U.S. Appl. No. 16/307,852, Election of Species Requirement, dated Oct. 5, 2022, 7 pages.
Co-pending U.S. Appl. No. 16/307,852, Preliminary Amendment filed Dec. 6, 2018, 8 pages.
Co-pending U.S. Appl. No. 16/307,852, Response to Apr. 26, 2022 Restriction Requirement, dated Aug. 22, 2022, 5 pages.
Co-pending U.S. Appl. No. 16/307,852, Response to Jun. 9, 2023 Final Office Action, dated Nov. 8, 2023, 7 pages.
Co-pending U.S. Appl. No. 16/307,852, Response to Oct. 5, 2022 Election of Species Requirement, dated Dec. 5, 2022, 5 pages.
Co-pending U.S. Appl. No. 16/307,852, Restriction Requirement, dated Apr. 26, 2022, 9 pages.
Co-pending U.S. Appl. No. 16/777,146, Non-Final Office Action dated Dec. 7, 2023, 13 pages.
Co-pending U.S. Appl. No. 16/777,146, Preliminary Amendment, filed Jan. 30, 2020, 5 pages.
Co-pending U.S. Appl. No. 16/799,062, Restriction Requirement dated Jan. 5, 2023, 6 pages.
Co-Pending U.S. Appl. No. 16/979,452, Final Office Action dated Jul. 13, 2021, 18 pages.
Co-Pending U.S. Appl. No. 16/979,452, Final Office Action dated Jun. 3, 2022, 15 pages.
Co-Pending U.S. Appl. No. 16/979,452, Non-Final Office Action dated Dec. 16, 2021, 16 pages.
Co-Pending U.S. Appl. No. 16/979,452, Non-Final Office Action dated Mar. 30, 2021, 16 pages.
Co-Pending U.S. Appl. No. 16/979,452, Non-Final Office Action dated Oct. 26, 2022, 14 pages.
Co-Pending U.S. Appl. No. 16/979,452, Preliminary Amendment filed Sep. 9, 2020, 8 pages.
Co-Pending U.S. Appl. No. 16/979,452, Response to Dec. 16, 2021 Non-Final Office Action, dated May 16, 2022, 15 pages.
Co-Pending U.S. Appl. No. 16/979,452, Response to Jul. 13, 2021 Final Office Action, filed Nov. 15, 2021, 8 pages.
Co-Pending U.S. Appl. No. 16/979,452, Response to Jun. 3, 2022 Final Office Action, dated Sep. 6, 2022, 11 pages.
Co-Pending U.S. Appl. No. 16/979,452, Response to Mar. 10, 2021 Restriction Requirement dated Mar. 17, 2021, 3 pages.
Co-Pending U.S. Appl. No. 16/979,452, Response to Mar. 30, 2021 Non-Final Office Action dated Jun. 24, 2021, 8 pages.
Co-Pending U.S. Appl. No. 16/979,452, Response to Oct. 3, 2023 Non-Final Office Action, dated Dec. 21, 2023, 13 pages.
Co-Pending U.S. Appl. No. 16/979,452, Restriction Requirement dated Mar. 10, 2021, 11 pages.
Co-pending U.S. Appl. No. 17/011,767, Final Office Action dated Jul. 20, 2022, 16 pages.
Co-pending U.S. Appl. No. 17/011,767, Non-Final Office Action dated Mar. 4, 2022, 49 pages.
Co-pending U.S. Appl. No. 17/011,767, Non-Final Office Action dated Nov. 16, 2022, 20 pages.
Co-pending U.S. Appl. No. 17/011,767, Response to Jul. 20, 2022 Final Office Action, dated Oct. 19, 2022, 8 pages.
Co-pending U.S. Appl. No. 17/011,767, Response to Mar. 4, 2022 Non-Final Office Action, dated Jul. 5, 2022, 8 pages.
Co-pending U.S. Appl. No. 17/011,767, Response to Oct. 21, 2021 Restriction Requirement, dated Dec. 11, 2021, 2 pages.
Co-pending U.S. Appl. No. 17/011,767, Restriction Requirement dated Oct. 21, 2021, 6 pages.
Co-Pending U.S. Appl. No. 17/048,755, Non-Final Office Action dated Jun. 17, 2021, 11 pages.
Co-Pending U.S. Appl. No. 17/048,755, Notice of Allowance dated Aug. 11, 2021, 10 pages.
Co-Pending U.S. Appl. No. 17/048,755, Preliminary Amendment filed Oct. 19, 2020, 7 pages.
Co-Pending U.S. Appl. No. 17/048,755, Response to Jun. 17, 2021 Non-Final Office Action dated Jul. 2, 2021, 8 pages.
Co-Pending U.S. Appl. No. 17/048,755, Response to May 13, 2021 Restriction Requirement, filed May 20, 2021, 2 pages.
Co-Pending U.S. Appl. No. 17/048,755, Restriction Requirement, dated May 13, 2021, 7 pages.
Co-Pending U.S. Appl. No. 17/434,321, Preliminary Amendment filed Aug. 26, 2021, 7 pages.
D. Gethin, A. Rees et al., "Studies on the 3D Printing of Nanocellulose Structures", Advances in Printing and Media Technology, vol. XLI(I), A2, (2014), 91-95.
Fink, Helen et al. Bacterial cellulose modified with xyloglucan bearing the adhesion peptide RGD promotes endothelial cell adhesion and metabolism—a promising modification for vascular grafts, Journal of Tissue Engineering and Regenerative Medicine, vol. 5, No. 6, Jun. 1, 2011, pp. 454-463.
Gatenholm P. et al. Bacteria fabricate 3D scaffolds for organ regeneration, Symposium 13: Biomedical research. New Biotechnology, Jul. 2014, vol. 31S, p. S52.
Guerreiro, Susana G. et al. Neonatal Human Dermal Fibroblasts Immobilized in RGD-Alginate Induce Angiogenesis. Cell Transplantation, 23, 2014, 945-957.
Halper, J.; Kjaer, M. (2014) Chapter 3: Progress in Heritable Soft Connective Tissue Diseases. Advances in Experimental Medicine and Biology, vol. 802, 26 pages.
Helenius G, H. Bäckdahl, A. Bodin, U. Nanmark, P. Gatenholm, B. Risberg, In vivo Biocompatibility of Bacterial Cellulose, J. Biomed. Mater. Res. A., 76, 431-438, 2005.
Huh et al. "From 3D Cell Culture to Organs-on-Chips," Trends Cell Biol. Dec. 1, 2011 (Dec. 1, 2011), vol. 21,155.12, pp. 745-754.
J.A. Rowley, G. Madlambayan, D.J Mooney, Alginate hydrogels as synthetic extracellular matrix materials, Biomaterials 20 (1999), 45-53.
Jia et al. "Engineering Alginate as a Bioink for Bioprinting," Acta Biomater. Oct. 1, 2015 (Oct. 1, 2015), vol. 10, Iss. 10, pp. 4323-4331.
Johnson, H. Y. Chung et al. Bio-ink properties and printability for extrusion printing living cells. Biomater. Sci. 2013, 1, 763-773.
Kumar, A. et al. Carbohydrate Polymers, "Application of xanthan gum as polysaccharide in tissue engineering: A review", published online Oct. 5, 2017, vol. 180 pp. 128-144.
Kunt, Emrah Deniz "Microfactory Concept with Bilevel Modularity" Graduate School of Engineering and Natural Sciences, Sabanci University, Fall 2011, 194 pages.
Kuzmenko, Y, S. Saemfors, D. Haegg, and P. Gatenholm, Universal method for protein bioconjugation with hanocellulose scaffolds for increased cell adhesion. Mater. Sci. Eng., C,2013. 33(8): p. 4599-4607.
L.Nimeskern, et al., "Mechanical evaluation of bacterial nanocellulose as an implant material for ear cartilage replacement", Journal of the Mechanical Behaviour of Biomedical Materials, 22 (2013), 12-21.
Lee, K. Y. and Mooney, D. J. Alginate: Properties and biomedical applications. Progress in Polymer Science, 37, 2012, 106-126.
Markstedt et al. "3D Bioprinting Human Chondrocytes with Nanocellulose-Alginate Bioink—for Cartilage Tissue Engineering Applications," Bio Macromolecules, Mar. 25, 2015 (Mar. 25, 2015) vol. 16, Iss. 5, pp. 1489-1496.
Martinez Avila, Hector et al.. 3D bioprinting of human chondrocyte-laden nanocellulose hydrogels for patient-specific auricular cartilage regeneration. Bioprinting. vol. 1-2, Mar. 1, 2016, pp. 22-35.
Martinez, Hector Avila, S. Schwarz, E.M. Feldmann, A. Mantas, A. Von Bomhard, P. Gatenholm, and N. Rotter, Biocompatibility evaluation of densified bacterial nanocellulose hydrogel as an implant material for auricular cartilage regeneration. Appl. Microbiol. Biotechnol., 2014. 98(17): p. 7423-7435.
Memic, Adnan et al. "Bioprinting technologies for disease modeling", Biotechnol Lett (2017) 39:1279-1290, 12 pages.
Michael, S. et al. Tissue Engineered Skin Substitutes Created by Laser-Assisted Bioprinting Form Skin-Like Structures in the Dorsal Skin Fold Chamber in Mice. PLOS. Mar. 4, 2013; vol. 8, No. 3, pp. 1-12; doi:10.1371/journal.pone.0057741.
Murphy S. V et al. 3D bioprinting of tissues and organs. Nature Biotechnology, Aug. 2014, vol. 32, No. 8, p. 773-785.
Nakamura et al. "Biomatrices and Biomaterials for Future Developments of Bioprinting and Biofabrication," Biofabrication, Mar. 10, 2010 (Mar. 10, 2010) vol. 2, Iss. 1, pp. 1-6.
Panwar et al. "Current Status of Bioinks for Micro-Extrusion-Based 3D Bioprinting Molecules," Molecules, May 25, 2016 (May 25, 2016) vol. 21, Iss. 6, pp. 1-26.
Petersen N, Gatenholm, P., Bacterial cellulose-based materials and medical devices: current state and perspectives, Applied Microbiology and Biotechnology, 91, 1277, 2011.
Qing, Gao et al. Coxial nozzle-assisted 3D bioprinting with built-in microchannels for nutrients delivery. Biomaterials, 61, 2015, 203-215.
Rutz et al. "A Multi-Material Bioink Method for 3D Printing Tunable, Cell-Compatible—Hydrogels," Adv Mater. Mar. 4, 2015 (Mar. 4, 2015), vol. 27, Iss. 9, pp. 1-18.
Salas, C et al. Nanocellulose properties and applications in colloids and interfaces. Current Opinion in Colloid and Interface Science. Oct. 30, 2014, vol. 19, No. 5, pp. 383-396.
Schuurman, W. et al., Macromolecular Bioscience, "Gelatin-Methacrylamide Hydrogels as Potential Biomaterials for Fabrication of Tissue-Engineered Cartilage Constructs", 2013, vol. 13, pp. 551-561.
Shariati et al., (2015) Hydrogels for Cell Encapsulation and Bioprinting. In: Turksen K. (eds) Bioprinting in Regenerative Medicine. Stem Cell Biology and Regenerative Medicine. Springer, Cham., pp. 89-108.
Teelahti, Toimi "Implementing Additive Manufacturing in Microfactories." M.Sc. Thesis, Tampere University of Technology, 2014, 71 pages.
Tuan, R. S. et al., "Skin and Bones (and Cartilage): The Dermal Fibroblast Connection", NIH Public Access (pp. 1-5) of Nat Rev Rheumatol. 2009, 5(9): 471-472, 5 pages.
Turksen, K. (editor) Bioprinting in Regenerative Medicine. Stem Cell Biology and Regenerative Medicine. Springer, Cham., 2015, 148 pages.
Ventola C.L. Medical Applications for 3D Printing: Current and Projected Uses. P&T, Oct. 2014, vol. 39 No. 10, p. 704-711.
Xu, Mingen et al. An cell-assembly derived physiological 3D model of the metabolic syndrome, based on adipose-derived stromal cells and a gelatin/alginate/fibrinogen matrix. Biomaterials 31 (2010) 3868-3877.
Zhao, Yu et al. "Three-dimensional printing of Hela cells for cervical tumor model in vitro", Biofabrication, 6, 2014, 035001, 10 pages.
Zhou, Y; The Application of Ultrasound in 3D Bio-Printing. Molecules. May 5, 2016, vol. 21 No. 590; pp. 1-25.

Also Published As

Publication number Publication date
WO2019145795A3 (en) 2019-10-03
US20210031456A1 (en) 2021-02-04
WO2019145795A2 (en) 2019-08-01

Similar Documents

Publication Publication Date Title
US11931966B2 (en) Systems and methods for optical assessments of bioink printability
JP7054268B2 (en) Systems, methods and media for artificial intelligence feedback control in laminated molding
US20190086899A1 (en) On-line Monitoring Method and System for Three-dimensional Printing
Elbadawi et al. Harnessing artificial intelligence for the next generation of 3D printed medicines
Mahmood et al. Artificial neural network algorithms for 3D printing
US11027535B2 (en) Systems and method for advanced additive manufacturing
US20190004496A1 (en) Systems and method for advanced additive manufacturing
US10639848B2 (en) Temperature determination in additive manufacturing systems
Welf et al. Quantitative multiscale cell imaging in controlled 3D microenvironments
Jin et al. Monitoring anomalies in 3D bioprinting with deep neural networks
CN103842793B (en) Sample is applied to device sensing and placement
JP7153067B2 (en) Method for adjusting equipment for manufacturing objects using additive manufacturing
JP7232771B2 (en) Discrimination method, learning method, discrimination device and computer program
CN106794605A (en) The heating of control surface
KR102520129B1 (en) Equipment for bio-ink transfer
Schmieg et al. Magnetic resonance imaging as a tool for quality control in extrusion‐based bioprinting
Ramesh et al. Advancing 3D bioprinting through machine learning and artificial intelligence
US20210197282A1 (en) Method and apparatus for estimating height of 3d printing object formed during 3d printing process, and 3d printing system having the same
US20230173545A1 (en) Method and system for classifying additive manufactured objects
CN111417986B (en) Color monitor setup refresh
KR102520802B1 (en) 3D bio-printer monitoring system and repairing system and method for correction of shape defects
US20210132358A1 (en) Method of preparing a microscope for imaging a sample
US20220339883A1 (en) Methods of calibration of a stereolithography system
US20220276478A1 (en) Method and apparatus for analysis of a sample by light sheet microscopy
US20200310366A1 (en) Layer configuration prediction method and layer configuration prediction apparatus

Legal Events

Date Code Title Description
FEPP Fee payment procedure

Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

AS Assignment

Owner name: CELLINK AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:THAYER, PATRICK;ABUSHALL, HANY;MARTINEZ, HECTOR;AND OTHERS;SIGNING DATES FROM 20180207 TO 20180214;REEL/FRAME:053762/0461

STPP Information on status: patent application and granting procedure in general

Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

STPP Information on status: patent application and granting procedure in general

Free format text: AWAITING TC RESP., ISSUE FEE NOT PAID

STPP Information on status: patent application and granting procedure in general

Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS

AS Assignment

Owner name: BICO GROUP AB, SWEDEN

Free format text: CHANGE OF NAME;ASSIGNOR:CELLINK AB;REEL/FRAME:066045/0256

Effective date: 20210812

AS Assignment

Owner name: CELLINK BIOPRINTING AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BICO GROUP AB;REEL/FRAME:065916/0402

Effective date: 20231129

Owner name: CELLINK BIOPRINTING AB, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BICO GROUP AB;REEL/FRAME:065916/0399

Effective date: 20231129

Owner name: BICO GROUP AB, SWEDEN

Free format text: CHANGE OF NAME;ASSIGNOR:CELLINK AB;REEL/FRAME:066077/0977

Effective date: 20210812

Owner name: BICO GROUP AB, SWEDEN

Free format text: CHANGE OF NAME;ASSIGNOR:CELLINK AB;REEL/FRAME:066077/0980

Effective date: 20210812

STPP Information on status: patent application and granting procedure in general

Free format text: AWAITING TC RESP., ISSUE FEE NOT PAID

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT RECEIVED

STPP Information on status: patent application and granting procedure in general

Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED

STCF Information on status: patent grant

Free format text: PATENTED CASE